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ABSTRACT 
Cellular demise is a well controlled and complex process.  The role of apoptosis and 
their contribution to disease pathogenesis are well known.  Yet, emerging evidence indicates 
that apoptosis interplay with autophagy may be more complex than previously thought.   
Autophagy may serve a pro-survival or cyto-destructive role depending on the cellular 
context and type of stressor.   In this context the requirement for PKCδ in MA and ischemia-
induced apoptotic cell death is briefly discussed.  
In the first portion of my thesis I investigated the cell death mechanism(s) underlying 
methamphetamine induced dopaminergic neurodegeneration.  Oxidative stress has been 
shown to trigger mitochondrial damage and the induction of autophagy, a protein clearance 
system.  We and others have previously demonstrated the induction of autophagy/apoptosis 
in MA-treated N27 cells; however the precise cellular mechanisms underlying MA-induced 
stimulation of autophagy/apoptosis remain unclear.  The present study explores the following 
issues:  (1) Does mitochondrial impairment precede autophagic induction.  If so, does it 
occur independent of or in association with UPS dysfunction?  (2) Does PKCδ, an oxidative 
stress sensor kinase, play a role in the mechanism of MA-induced cell death?  If so, does it 
activate caspase-3 dependent cell death events?  (3)  What is the exact contribution of 
autophagy, is it cytoprotective or prodeath mechanism?  Taken together, our results suggest 
that MA-induced dopaminergic neurotoxicity is likely caused, at least in part, by pronounced 
proteolytic cleavage of PKCδ and associated oxidative cell signaling events.  Additionally, 
MA, through the induction of mitochondrial stress, activates autophagy as a cytoprotective 
mechanism to minimize the magnitude of neuronal cell death. 
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In the second portion of my thesis I evaluated the role of PKCδ dependent cell death 
signaling events in striatal neuronal degeneration.  Striatal ischemia is also often associated 
with oxidative stress associated cell death following reperfusion post cerebral ischemia.  
Using an OGD model of ischemia we demonstrated the occurrence of apoptotic cell death in 
mouse primary striatal neurons.  As a key detector of oxidative stress, depolarization of 
mitochondria membrane potential and cytochrome c release into the cytoplasm are signs of 
mitochondrial impairment.  Additionally, downstream events involve caspase-3 cleavage and 
PKCδ activation.  Caspase-3 mediated proteolytic cleavage of PKCδ in the striatum as a 
result of ischemic insult is a novel finding which suggests PKCδ plays a regulatory role in 
striatal neuronal cell death.  This finding is further supported from our data showing that cell 
death is attenuated in PKCδ knockout mice.  Previous studies have shown neuron subtype 
specific susceptibility to ischemic insult in the striatum. Our investigation reveals that 
GABAergic neurons are more vulnerable to cell death during striatal ischemia, confirming 
different neuronal subtypes exhibit varying degrees of vulnerability to ischemic damage.   
In conclusion, despite the use of two different types of cellular injury models, namely 
MA and OGD-induced neurotoxicity, our findings underscore the importance of caspase-3 
mediated PKCδ dependent cell death events  in apoptotic cell death.  This study demonstrates 
that PKCδ might represent a common cell death mechanism, facilitating neuronal demise 
following exposure to diverse cell stressors that are capable of causing apoptotic cell death. 
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Chapter I:  Background and Literature Review 
THESIS ORGANIZATION 
The present thesis contains two separate manuscripts, both prepared for submission to 
Journal of Neurochemistry. Titles include “PKCδ is a key mediator of MA-induced cell death 
in N27 dopaminergic neuronal cells: Role for autophagy and UPS,” and “Proteolytic 
activation of PKCδ is involved in neuronal death after OGD in mouse primary striatal 
cultures.”  Each paper has been incorporated into chapters II and III respectively. Below is a 
literature review for each manuscript. 
 
PKCδ IS A KEY MEDIATOR OF MA-INDUCED CELL DEATH IN N27 
DOPAMINERGIC NEURONAL CELLS: ROLE FOR AUTOPHAGY AND UPS  
 
Methamphetamine-induced Cytotoxicity in Neuronal Cells 
Methamphetamine (MA) can cause neurotoxic damage to the monoaminergic system in 
the rodent and primates.  Several dopamine (DA) markers are affected by this drug in the 
rodent brain, including decrease in tyrosine hydroxylase activities, depletion of striatal 
dopamine levels and loss of dopamine transporters (Seilden et al., 1987; Cadet et al., 1998; 
Krasnova et al., 2005).  These observations taken together indicate that Methamphetamine 
causes degeneration of the striatal projections of dopamine neuron terminals.   
Both reactive oxygen species (ROS) and reactive nitrogen species (RNS) have been 
known to be involved in several neurodegenerative diseases such as Parkinson’s disease, 
Alzheimer’s disease and amyotrophic lateral sclerosis (Imam et al., 2001; Cadet et al., 1998).  
Many earlier studies have shown that the role of oxygen-based free radicals may be a critical 
event in MA-induced neurotoxicity (Yamamoto and Zhu et al., 1998; Imam et al., 1999).  
Administration of antioxidants, such as ascorbic acid or vitamin E, attenuates MA-induced 
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neuronal toxicity (Wagner et al., 1985); conversely inhibition of superoxide dismutase (SOD) 
increases its neurotoxicity (Wagner et al., 1989).  MA-induced neurotoxicity is also 
associated with the production of hydroxyl and superoxide radicals (Krosnova et al., 2001), 
which are thought to participate in the toxic effects of MA via free radical-mediated protein 
oxidation and DNA damage.  The increase in superoxide radicals is probably due to the 
release of DA in the brain after MA administration (Baldwin et al., 1993), a secondary effect 
of the drug–induced redistribution of DA from synaptic vesicles to the cytosol followed by 
its release into the extracellular space by DA transporters (DAT) resulting in increased DA 
levels in the synaptic cleft (Sulzer et al., 1995).   
The monoamine drug, Methamphetamine, is often used as an experimental model for 
Parkinson’s disease (PD) due the close resemblance to disease pathophysiology.  Recently, 
Fornai et al., showed that MA-induced multilamellar whorls are α-synuclein and ubiquitin 
positive intracellular whorls, which suggest dysfunction of the ubiquitin-proteasome system 
(UPS), hence, sharing similarities with the Lewy bodies present in PD (Fornai et al., 2004b; 
Lazeri et al., 2007).  Consistent with previous reports (Chu et al., 2006; Larsen et al., 2002), 
autophagosomal vacuoles (AV) induced by MA administration in midbrain neurons, appear 
to play a role in the clearance of these protein aggregates (aggresomes).  The AVs in several 
studies showed engulfment of a variety of cytosolic organelles and contain partially digested 
materials that are positive for ubiquitin. 
 
Autophagy and Programmed Cell Death (PCD) 
 Autophagy is characterized by the process of having cytoplasmic organelles or long-
lived proteins delivered to lysosomes for enzymatic degradation.  In recent years, growing 
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number of studies have highlighted the relationship of autophagy-induced cytoprotective 
response with protein aggregation, and its potential in the clearance of damaged proteins.  
Autophagy has been termed as Type II programmed cell death (PCD) and is characterized by 
the accumulation of autophagic vacuoles.  Increased accumulation of autophagic vacuoles 
have been described in Parkinson’s disease, Alzheimer disease, Huntington disease, prion 
disease, amyotrophic lateral sclerosis and many other neuronal diseases.  Lewy bodies is a 
major protein in PD, α-synuclein induces autophagic vesicles along with impairment of UPS 
(Shintani et al., 2004). 
 Autophagy involves the formation of the double membrane structures called 
autophagosomes which expands from a phagophore while surrounding a portion of the 
cytoplasm and sequestering organelles.  Subsequently, they fuse with the lysosome to form 
autolysosomes (Fig. 1).  Contents within the autophagosomes are then degraded by the 
lysosomal enzymes, including acid hydrolase and permease (Klionsky 2007; Chu et al., 
2006).  Membranes from engulfed organelles become compacted and can form multilamellar 
whorls, particularly at the autolysosomal stage (Iacovelli et al., 2006).  This forms the basis 
for accumulation of an autofluorescent chemical monodansylcadaverine (MDC), which has 
an affinity for acidic membrane-rich compartments.  Though MDC is often used as an 
indicator for acidic vacuoles and labeling autophagic vacuole (AV) maturation, it cannot be 
used as a specific AV marker (Chu et al., 2006).  Alternatively, the membrane associated 
protein light chain 3 (MAP-LC3) is a highly useful AV marker (Mizushima et al., 2008), 
which is a mammalian analog of Atg 8 (autophagy-related genes).    
 A significant conundrum that has emerged recently since 1970s when Beaulaton and 
Lockshin first suggested a role for autophagy in cell death, suggesting that there might be 
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coordination between apoptosis and type II cell death.  Many subsequent studies have shown 
that although in most situations, autophagy may initially function as a cytoprotective 
mechanism, but as the damage becomes too extensive, cells may undergo apoptosis or 
excessive autophagy and may lead to cell death ultimately (Klionsky 2007).  Understanding 
the dual role of autophagy will improve our knowledge on the signal transduction pathway 
that regulates these processes 
Fig. 1 
 
Figure 1.  The formation of autolysosomes and inhibitors effective at difference stages 
in the formation process. (Source: Nature Reviews, 2005)  
 
Genes Involved in Autophagy 
Autophagosome formation involves a series of autophagy related genes (ATG genes), 
which were first discovered in yeast.  There are more than 20 genes in yeast that encode 
proteins essential for the autophagy process (Levine et al., 2006).  Many of them participate 
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in an ubiquitin-like conjugation, and have been categorized into two conjugation systems: the 
Atg12-Atg5 conjugation system and Atg8 (LC3)-PE conjugation system (Ferraro et al., 
2007).  Atg12 is an ubiquitin-like protein that is firstly activated by Atg7, which works as an 
ubiquitin-activating enzyme E1, and covalently links to Atg5 to form conjugates.  Atg10 is 
involved in this process, functioning as an E2-like enzyme for Atg12-Atg5 conjugation 
(Yang et al., 2005).  Multiple Atg12-Atg5 conjugates are then cross-linked with Atg16 to 
form Atg12-Atg5-Aatg16 complexes for pre-autophagosomal membrane elongation (McCray 
et al., 2008; Yang et al., 2005).  
The other ubiquitin-like protein essential for autophagy is Atg8, the mammalian 
ortholog of which is MAPL1LC3 (microtubule-associated protein 1 light chain 3). LC3 is 
proteolytically cleaved by Atg4 before activation by E1-like enzyme Agt7.  LC3 is then 
transferred to E2-like protein Atg3 that catalyzes LC3 to an active form of LC3-II 
(membrane bound) and conjugates to the lipid phosphatidyl-ethanolamine (PE).  This 
lipidation of LC3 leads to a conformational change essential for its binding to the membranes 
of pre-autophagosomes and autophagosomes.  LC3-PE conjugations are located on the outer 
surface of autophagosomes and are removed prior to fusion with lysosomes.  To date in 
mammalian cells, LC3 is the most reliable marker for autophagosome formation, and the 
relative amount of LC3-II reflects the abundance of autophagosomes.  Consequently, LC3 
staining is used widely as a histological marker for autophagosomes, and accumulation of 
LC3-II is used for the detection of autophagic activity.  
Other genes related to autophagy include Atg6, which its mammalian ortholog is Beclin 
1.  Atg6 belongs to a class III phosphoinositide 3-kinase (PI3K) complex, participates in 
early autophagosome formation that might take place before Atg5-Agt12 and LC3-PE in the 
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autophagosome formation process (Baehrecke, 2005).  Atg1 complex and Atg9 complex also 
plays a role in autophagosome formation mechanism.  Phosphorylation of some of the Atg 
proteins is one of the mechanisms through which autophagy is regulated.  On the other hand, 
a better studied central signaling pathway is through mammalian target of rapamycin 
(mTOR), a serine/threonine kinase.  Rapamycin inhibits mTOR and induces autophagy while 
activation of mTOR inhibits the process (Chu, 2006).  The biochemical mechanism by which 
mTOR kinase inhibits autophagy is not fully understood, but it involves mTOR inhibiting 
autophagy by controlling both transcription and translation and by modifying Atg proteins 
(kinase Atg1 in yeast) and therefore interfering with the formation of autophagosomes 
(Baehrecke, 2005; Kamada et al., 2000; Klionsky, 2005).  Activation of class I 
phosphatidylinositol 3-kinase (PI3K) leads to the phosphorylation of plasma membrane lipids 
that recruit and activate Akt/protein kinase B, an upstream regulator of autophagy.  
Activation of Akt/PKB represses autophagy, tuberous sclerosis complex and small G protein 
Rheb (Baehrecke, 2005) link tyrosine receptor kinases to mTOR activation and thereby 
repress autophagy in response to insulin-like and other growth factor signals.  The 
relationship of these genes in autophagy formation process is illustrated in Figure 2.  
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Fig. 2 
 
Figure 2.  Genes involved in autophagy formation process. (Source: Cell Signaling) 
 
Oxidative Stress and its Role in Autophagy Induction 
 The role of reactive oxidative species (ROS) has been extensively investigated in 
many neurodegenerative diseases, including Parkinson’s disease, Alzheimer’s disease and 
Huntington disease, as well as in aging and drug abuse in the CNS.  In order to prevent 
damage caused by free radicals generated under these conditions, cells activate different 
mechanisms in response to oxidative stress (Kaushik et al., 2006).  Various defense 
mechanisms have been discovered to protect cells during oxidative stress, including up-
regulation of antioxidants, removal of specific damaged proteins by the ubiquitin-proteasome 
system and removal of damaged proteins and organelles by the autophagy-lysosomal system 
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(Scherz-Shouval et al., 2007a).  Autophagy occurs at a low basal level in all cells and it 
contributes to homeostatic functions such as protein and organelle turnover.  However, it is 
rapidly upregulated in stressful situations such as nutrition deprivation, growth factor 
depletion and hypoxia.  Autophagy is also upregulated in cells that are exposed to toxins and 
stressors and are in need to rid themselves of damaging cytoplasmic components, including 
oxidative stress, accumulation of aggregate prone proteins (Levine et al., 2006).  A study 
recently provides evidence that generation of hydrogen peroxide during starvation serves as a 
signaling molecule that initiates autophagosome formation (Scherz-Shouval et al., 2007b).  
Since defective mitochondria and peroxisomes produce more hydrogen peroxide than normal 
ones, it is of great importance for cells, especially in long-lived postmitotic cells, to 
selectively degrade dysfunctional organelles (Liu et al., 2004). 
 Methamphetamine-related quinone formation is thought to be associated with the 
generation of superoxide radicals and hydrogen peroxide during quinone redox cycling.  
Dopamine release caused by MA is accompanied by redox cycling of dopaquinone and 
consequent formation of oxygen-based radicals such as superoxide radicals.  Additionally, 
MA can induce changes in the levels of glutathione and of antioxidant enzymes, increase 
lipid peroxidation and induce formation of protein carbonyls, which provide further 
amplification of oxygen-based radicals induced neurotoxicity in drug treated cells (Cadet et 
al., 1998).   
 
Mitochondrial ROS and Autophagy 
 Mitochondria plays a central role in cellular metabolism and apoptosis.  During 
apoptosis, a variety of cellular signals activated from stimuli can be sensed by the 
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mitochondria and reacts by releasing proapoptotic proteins into the cytosol such as   
cytochrome c, an upstream regulator of apoptosis (Ko et al., 2005).  Upon release, it can then 
activate downstream effector caspases, leading to apoptosome complex (Apaf-1 and caspase-
3, capase-9) formation (Katoh et al., 2004).  An indicator of the cell viability is the 
maintenance of mitochondrial inner membrane transmembrane potential (Iijima, 2006).  
Electron transport along the respiratory chain generates mitochondrial membrane potential, 
this electrochemical gradient is essential for ATP synthase activity in the phosphorylative 
pathway.  A frequent occurrence in the mitochondrial electron transport chain is the escape 
of electrons, results in the production of oxygen radicals, which are often converted into 
hydrogen peroxide or other reactive oxygen species (ROS).  Mitochondria are a major source 
of intracellular ROS production, and ROS has been implicated as second messengers and are 
known to participate in physiological processes, such as apoptosis and proliferation (Ko et al., 
2005). 
Mitochondrial ROS is normally detoxified by superoxide dismutase (SOD), glutathione 
peroxidase, heme peroxidase and catalase (Bandyopadhyay et al., 1999). SOD lowers the 
steady state levels for superoxide (O2
-
), while catalase and peroxidases lower the steady state 
levels for hydrogen peroxide (H2O2).  In addition to the primary defense against ROS by 
antioxidant enzymes, secondary defense are free-radical scavengers, such as ascorbate and 
reduced glutathione (Bandyopadhyay et al., 1999).  However, when elimination rates of ROS 
is overwhelmed by ROS generation, accumulation of ROS results in the mitochondrial 
damage.  It is known that TOR inhibits autophagy, which also regulates mitochondrial 
biogenesis and activity.  By inhibiting autophagy, TOR allows defective mitochondria to 
accumulate (Blagosklonny, 2007).   
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Ubiquitin-Proteasome System (UPS) and Autophagy 
Pathways involved in protein degradation are classified into two major pathways, 
namely, the lysosomal pathway and nonlysosomal pathway.  The lysosomal pathway is 
responsible for degradation of extracellular proteins by endocytosis and for bulk 
degradation of long-lived proteins and organelles by macroautophagy.  The nonlysosomal 
pathway is characterized by the highly selective degradation of short-lived proteins under 
basal metabolic conditions.  This process involves tagging susceptible proteins with 
ubiquitin followed by proteasome hydrolysis (Larsen et al., 2002).  This pathway is called 
ubiquitin–proteasome system (UPS), a primary mechanism for degrading and elimination of 
misfolded intracellular proteins.  The presence of ubiquitinated proteins is an important 
hallmark of neurodegeneration (Iacovelli et al., 2006).  The UPS becomes abnormally 
activated during oxidative stress, inappropriate gene splicing and abnormal proteolytic 
cleavage.  Under these conditions, the UPS may not be able to function normally and 
degrade the damaged proteins, resulting in protein accumulation in the cells leading to 
ultimate cell dysfunction and cell death (Chung et al., 2001).   
UPS dysfunction has been shown to be prevalent in Parkinson’s disease (PD), where 
pathological changes include loss of dopaminergic neurons in the substantia nigra pars 
compacta and its characteristic accumulation of intracytoplasmic inclusion bodies.  
Although the molecular mechanism of the loss of dopaminergic neurons is not fully 
understood, UPS dysfunction has been proposed as one of the factors in PD pathogenesis 
(Zafar et al., 2007).  We have previously shown that dieldrin, a potential PD producing 
pesticide, induces neurodegeneration via UPS dysfunction (Sun et al., 2005). Furthermore, 
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it has also been demonstrated by our research group that proteasome inhibitor MG132 leads 
to apoptotic cell death in N27 immortalized dopaminergic neuronal cells and the loss of 
tyrosine hydroxylase-positive neurons in mouse substantia nigra when administered in vivo 
(Sun et al., 2006).   
Impairment of the UPS occurs in several neurodegenerative diseases as well as cellular 
toxicity induced by amphetamine derivatives, such as methamphetamine (MA).  Studies 
have shown that MA induces ubiquitin-positive intracellular bodies within dopaminergic 
neurons in the substantia nigri (Fornai et al., 2004a).  A recent study in chronic MA abusers 
demonstrates the occurrence of ubiquitin-positive inclusions within nigral dopaminergic 
cells (Quan et al., 2005).  Another study showed that MA-induced ubiquitin inclusions only 
occur in dopaminergic neurons, and not formed in non-dopaminergic striatal neurons 
(Fornai et al., 2007).   Increased extracellular DA levels induced by MA is coincident with 
increased levels of ROS (Lazzeri et al., 2007), leading to early stage aggregates often 
known as autophagic granules seen after MA administration (Larsen at el., 2002).  These 
neuronal inclusions consist of proteins belonging to the multi-enzymatic complex, the UPS 
(Iacovelli et al., 2006).  Recent studies have shown that there is a compensatory relationship 
between the two protein degradation pathways, UPS and autophagy-lysosomal pathway 
(Fig. 3).  
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Fig. 3 
  
Figure 3. Association between UPS and autophagy suggests UPS as a possible trigger 
for autophagy. (Bate et al., 2009) 
 
 
Protein Kinase C Delta and Apoptosis 
Apoptosis is a highly regulated cellular suicidal program.  It is controlled by a complex 
cellular signaling network, several members of the protein kinase C (PKC) family have been 
identified as a substrate for caspases (Griner et al., 2007).  PKC belongs to a family of 
phospholipid-dependent serine/threonine members, which plays a central role in growth 
factor signaling pathway and regulatory cellular functions, including cell proliferation, cell 
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differentiation, and cell death (Busa, 2003).  PKC family is composed of many isozymes that 
can be categorized into three groups including the classical PKCs (cPKCs): α, βI, βII and γ; 
novel PKCs (nPKCs): δ, ε, ε and ζ; atypical PKCs (aPKCs): δ, λ and η (Maher, 2001; Zhang 
et al., 2007).  While cPKCs require Ca
2+
 and diacylglycerol (DAG)/phorbol esters for their 
activities, nPKCs do not require Ca
2+
 for activation but are still activated by DAG/phorbol 
esters.  aPKCs are independent of both Ca
2+
 and diacylglycerol (DAG)/phorbol esters (Griner 
et al., 2007).  PKCδ, which is a member of nPKC, is primarily activated through DAG in the 
C1 domain at the plasma membrane.  Another activation mechanism involves response to 
phorbol esters, PKCδ can be activated by proteolysis phorphosphorylation and organellar 
translocation during apoptosis (Emoto et al., 1995; Griner et al., 2007).    
The intracellular distribution of PKCδ is altered upon activation (Kraft et al., 1983).  It 
is demonstrated that PKCδ can translocate from the cytosol to the mitochondria (Li et al., 
1999).  In that study, PKCδ activation by TPA resulted in cell death in keratinocyte cells, 
suggesting that PKCδ translocation to the mitochondria serves as a precursor to cell death.  
Additionally, PKCδ translocation to the nucleus from cytoplasm in response to various 
apoptotic agents including gamma-irritation and Fas-ligand has been demonstrated (Blass et 
al., 2002; DeVries et al., 2002).  In fact, nuclear localization signal on the COOH-terminal in 
PKCδ has been shown to be required for both nuclear localization and apoptosis (DeVries et 
al., 2002).  Furthermore, PKCδ is also a caspase-3 substrate, expression of the catalytic 
fragment cleavage product is a potent inducer of apoptosis in several cell types (Denning et 
al. 2002; Sitailo et al., 2004; D’Costae et al., 2005).  Previously, we have demonstrated that 
proteolytic activation of PKCδ plays a critical role in oxidative stress-induced dopaminergic 
cell death (Anantharam et al., 2002; Kaul et al., 2003; Yang et al., 2004).  Proteolytic 
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cleavage of PKCδ (74kDa) by caspase-3 results in a 41kDa catalytic subunit and a 38 kDa 
regulatory subunit, leading to persistent activation of the kinase (Kaul et al., 2003; Yang et 
al., 2004).  Blockage of proteolytic activation of PKCδ by overexpression of the kinase-
dominant-negative PKCδ mutant, cleavage-resistant PKCδ mutant or siRNA directed against 
PKCδ almost completely prevented the dopaminergic cell death (Kaul et al., 2003; Kitazawa 
et al., 2003; Yang et al., 2004).  
Programmed cell death is mediated, in part, by caspases.  Caspases, a family of cysteine 
proteases that cleave proteins after aspartate residues, are essential for the execution of 
apoptosis (Cohen, 1997).  Caspase-8, -9, -10 participate in the initiation of phase of the 
apoptosis whereas caspase-3, -6 and -7 are involved in the execution phase of apoptosis, 
caspase-2 can function as both initiator and executor caspase (Duan, 1997).  Activation of the 
effector caspase leads to cleavage of many cellular proteins that trigger nuclear breakdown, 
loss of mitochondrial membrane potential and cell death.  Caspase-3 is an effector caspase 
that can be activated by both caspase-8 and caspase-9.  Despite PKCδ being a target of 
caspase-3 and is activated relatively late in the cell death signaling pathway, inhibition of 
PKCδ can reduce apoptotic activity during oxidative stress and other chemical (drugs) or 
physical (UV radiation) damage in the cells (Sitailo at al., 2004).  In addition, organochlorine 
pesticide such as dieldrin has been shown to activate caspase-3 that proteolytically triggers 
PKCδ and induce apoptotic cell death in dopaminergic cells (Kitazawa et al, 2003).  These 
reports suggest a positive feed back amplification loop set by PKCδ activation that amplifies 
the caspase cascade and helps the cells commit to cell death.   
Two major pathways of cell death have been identified: the receptor-mediated or 
extrinsic pathway and the mitochondrial or intrinsic pathway (Busa, 2003).  The extrinsic 
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pathway is greatly studied in the tumor necrosis factor-alpha (TNF-α) superfamily, 
associated with the binding of ligand to receptors, which activate caspase-8, an initiator 
caspase (Ashkenazi and Dixit, 1998).  In the intrinsic cell death pathway, characterized by 
the involvement of the mitochondria, the release of cytochrome c and other proapoptotic 
events which has been described in the previous sections.  In recent years, protein kinase C 
(PKC) has been implicated to involve in several ischemic and reperfusion insults in multiple 
organs (Downey and Cohen, 1997; Padanilam, 2001).   However, most of this work has been 
focused on the role of PKC in the cardiac system.  Ischemic insult can result in activation of 
several PKC isozymes, which may mediate different and sometimes opposing functions 
(Bright et al., 2005).   
Growing body of literature support the involvement of PKCδ proteolytic activation in 
the apoptosis pathway, including caspase activation and regulation of mitochondrial function 
(Brodie and Blumberg, 2003).  This intrinsic pathway has also been shown previously by our 
group (Anantharam et al., 2002). Treatment of dopaminergic cells with 
methylcyclopentadienyl manganese tricarbonyl (MMT), an additive to the gasoline in the 
1960s, induces caspase-3 mediated proteolytically cleaved PKCδ- dependent apoptosis.  The 
pathway involved cytochrome c release from the mitochondria via caspase-3 dependent 
proteolytic cleavage of PKCδ.  Thus far, several studies from our group (Kanthasamy et al., 
2003) have confirmed that PKCδ activation by proteolytic cleavage plays a key role in 
promoting cell death, especially in neuronal cells.   
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PROTEOLYTIC ACTIVATION OF PKCδ IS INVOLVED IN NEURONAL DEATH 
AFTER OGD IN MOUSE PRIMARY STRIATAL CULTURES 
 
Striatal Ischemia 
Ischemic stroke is a complex event and the region of the focal stroke can be recognized 
as either the core territory or the ischemic penumbra.  The core is the center of the territory, 
characterized by blood flow deficits, low ATP or energy levels, ionic disruptions and 
metabolic failures, all contribute to the fast cell death progress.  The ischemic penumbra, 
which is the peripheral region of the ischemic stroke, suffers milder insults, due to residual 
perfusion from the blood vessels (Lo, et al., 2003).  However, as ischemic stroke is normally 
treated by restoration of oxygen to the brain in a normal medical procedure, a result of 
oxygen reperfusion (re-oxygenation) after ischemic insult, this can actually cause immediate 
cell death of originally surviving cells.  This form of apoptotic cell death is termed “delayed 
ischemic cell death” (Mattson et al., 2000).  The precise mechanism for this type of cell death 
is not fully understood.  The cell death induced by cerebral ischemia is complex; this form of 
delayed cell death occurring after cerebral ischemia may result from at least three 
mechanisms: excitotoxicity and ionic imbalance, oxidative/nitrosative stress, and apoptotic-
like cell death (Lo et al., 2003).  Neurons have high metabolic rates and little energy is 
reserved and mitochondria serves as the main energy source in the brain.  Consequently, 
disturbances of the mitochondrial function can lead to ATP depletion and release of apoptotic 
inducing factor (AIF) from the mitochondria (Panickar et al., 2005). 
Necrotic and apoptotic cell death is another way of categorizing ischemic neuronal 
death.  Necrosis is an acute cell death procedure occurring shortly after ischemic insult and in 
the core of the ischemia area, while apoptosis is a slowly progressing cell death procedure 
happening in the peri-infarct zone (Iijima, 2006).  Recently, mitochondria are focused as the 
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regulators of neuronal death, due to their involvement in AIF release.  Increased glutamate 
during ischemia opens the NMDA receptor, causing Ca
++
 abrupt release and resulting in 
neuronal death (Iijima, 2006).  This Ca
++
 deregulation stresses the importance of Ca
++
 and 
Na
+
 homeostasis for cell survival.  Sustained increase in intracellular Ca
++
 even after 
reperfusion leads to activation of Ca
++
-dependant enzymes and initiation of apoptotic cascade.   
Disruption of the Ca
++
 buffering system, leads to Ca
++
 deregulation as a result of 
depolarization of the mitochondrial membrane and trigger Ca
++ 
efflux from matrix to the 
cytoplasm, ultimately cell death (Kruman et al., 1999).  The following studies highlight the 
importance of mitochondrial homeostasis in ionic homeostasis and initiation of apoptosis 
cascade.  
Mitochondrial release of apoptotic factors is influenced by the Bcl-2 family, which 
includes Bax, Bak, Bad, Bim, Bid, as well as proteins that are anti-apoptotic, including Bcl-2, 
Bcl-xl (Daniel and Korsmeyer, 2004).  Bid is a proapoptotic protein that promotes 
cytochrome c release and activation of caspase-8 substrate, which then activate the cell death 
pathway, hence contributing to ischemic cell death.  Furthermore, Bid cleavage was detected 
before caspase-3 cleavage, suggesting it is an upstream mediator.  Consistent with its 
proapoptotic role, cell death was significantly reduced in Bid knockout mice (Plesnila et al., 
2001).  Taken together, studies suggest that Bid may serve as a critical mediator of cell death, 
via mitochondrial dysfunction.   
Neuronal Subtype and Classification 
Striatal neurons have been known to be susceptible to cerebral ischemia and loss of 
striatal GABAergic projection neurons is one of the hallmarks in transient ischemia.  
GABAergic neurons are very sensitive to ischemic effects in the striatum.  GAD is a rate 
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limiting enzyme in GABA biosynthesis that has been used to express GABA-ergic neurons 
in the brain.  Intrastriatal neurons consist of ~90% medium spiny projection neurons and 
~10% interneurons (Marin et al., 2000).  There are several subtypes in the GABAergic 
neuronal population, including the Ca
++
 binding protein positive neurons, calbindin, 
calretinin or parvalbumin, in the brain regions (Schwaller et al., 2002; Ulfig, 2002), where 
they function as Ca
++
 buffering system.  In the adult striatum, the majority of the medium 
spiny projection neurons (75-82%) display calbindin immunoreactivity (Parent et al., 1996; 
Falk et al., 2006).  Whether calbindin plays a protective role in the CNS insult is 
controversial and existing data are conflicting (Yenari et al., 2007).  Intracellular Ca
++ 
accumulation is known to potentiate ischemia induced injury in the brain (Kristian et al., 
1998).  Some studies have shown that Ca
++
 binding protein (CaBP) containing neuronal 
populations are better able to survive ischemic (Goodman et al., 1993) and excitotoxic insult 
(Mattson et al., 1991) than those that lack CaBP.  While these studies suggest the beneficial 
role of the CaBP, others have suggested that the presence of CaBP has nothing to do with the 
resistance to CNS insults (Freund et al., 1992).  In a study using overexpressing CaBP with 
viral vector, protects neurons from stroke insult (Yenari et al., 2007), supporting the 
protective role of CaBP.  
 
 
Role of PKCδ in Cerebral Ischemia 
As previously discussed, phosphorylation of PKCδ can regulate the proteolytic 
activation of the kinase during oxidative stress, which consequently influences the apoptotic 
cell death in dopaminergic neuronal cells (Kaul et al., 2005).  PKCδ is shown to be an 
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oxidative sensitive kinase that can be activated by caspase-3 dependent proteolytic cleavage 
to induce apoptotic cell death in cell cultures of Parkinson’s disease (Kaul et al., 2003; 
Kanthasamy et al., 2004).  In this study, we recapitulated ischemic stress by using oxygen-
glucose deprivation techniques in primary striatal neurons.  The role of mitochondria 
mediated oxidative cell signaling event is discussed below.  
 Caspases are activated during cerebral ischemia (Krajewski et al., 1999; Plesnila et al., 
2001) and ischemic cell death can be attenuated with caspase inhibitors (Le et al., 2002; Hara 
et al., 1997).  Among the many caspases involved in cell death, caspase-3 is crucial in 
neuronal pathological conditions, including cerebral ischemia (Nicholson, 1999).  Caspase-3 
cleavage has been reported in many studies associated with oxygen/glucose deprivation, a 
well-characterized model for cerebral ischemia research (Krajewski et al., 1999; Shen et al., 
2004).  In the same study, they showed nicotinamide (vitamin B3) may be acting through the 
mitochondrial pathway, blocking capase-3 cleavage and protecting cells from ischemic cell 
death.  Another study showed blockage of caspase-3 with neurotrophins in cerebral ischemia 
injury, protected the neurons from apoptotic cell death (Kim et al., 2005).  Likewise, in a 
caspase-3 knockout mice study, neuroprotection in cerebral ischemia-induced damage 
suggested caspase-3 as a central mediator in cerebral ischemic cell death (Le et al., 2002).   
The mode of cell death correlates well with other studies observed during delayed 
cerebral reperfusion injury which contributes to irreversible brain damage seen after stroke 
(Lipton, 1999).  Increase in PKCδ expression was noted in the penumbral area, suggesting a 
role for this isozyme in reperfusion injury (Phan et al., 2002).  Bright et al showed that PKCδ 
selective inhibitor peptide δV1-1 protected against cerebral ischemic-reperfusion damage in 
both in vivo and in vitro models of cerebral ischemia.  
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Oxidative Stress in Cerebral Ischemia 
 Injury to the brain in cerebral ischemia is caused from the interruption of blood flow, 
and then a subsequent reoxygenation (ischemia/reperfusion).  The brain is exceptionally 
sensitive to oxidative damage due to its high use of oxygen and glucose and enrichment of 
peroxidizable fatty acids and Fe ascorbate/ Fe pro-oxidants (Floyd and Carney, 1992).  
Cerebral ischemia involves several complex metabolic events, including the generation of 
nitrogen and oxygen free radicals.  Increased production of free radicals in cerebral ischemia 
can arise from several mechanisms including glutamate stimulation of NMDA receptors 
(Lafon-Cazal et al., 1993), mytochondrial dysfunction (Braughler and Hall, 1989), activation 
of neuronal nitric oxide synthase (Lipton and Rosenberg, 1994), cyclooxigenase 2 (Iadecola 
et al., 1999), metabolism of free fatty acids released during ischemia (Schmidley, 1990) and 
others.  These free radicals and other reactive oxygen species mediate much of the damage 
caused by transient cerebral ischemia, resulting in molecular pathological conditions such as 
damage to cellular membrane, proteins and nucleic acids and induction of apoptotic events.  
Major players include nitric oxide, which are generated by nitric oxide synthases (NOS), 
specifically NOS 1 in ischemic damaged neurons, and superoxide, which is activated through 
nitric oxide synthases, xanthine oxidase, leakage from the mitochondrial electron transport 
chain and other mechanisms (Love, 1999). The toxicity of nitric oxide, superoxide and 
peroxynitrite results in modifications of macro molecules, especially DNA, and induces 
apoptotic and necrotic cell death pathways.  Reoxygenation during reperfusion provides 
oxygen as a substrate for numerous enzymatic oxidation reactions and for mitochondrial 
oxidative phosphorylation to produce adenosine triphosphate (Saito et al., 2005). Oxygen 
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free radical reactions and oxidative damage are held in check by antioxidant defense 
mechanisms.  Superoxide dismutase (SOD) is an endogenous antioxidant that catalyses the 
dismutation of the superoxide anion radical. SOD plays an important role in the defense 
against free radical damage in reperfusion injury and helps in reducing the infarct size during 
ischemia and reperfusion (Kim et al., 2002; Zimmermann et al., 2004).  However, when 
excessive amount of oxygen free radicals are produced or defense mechanisms are impaired, 
oxidative stress may result in aging, carcinogenesis and stroke (Floyd, 1990).  Subtle changes, 
such as oxidative damage induced loss of glutamine synthetase activity, is a key event in 
stroke induced brain injury (Nakamura and Stadtman, 1984).   Another determination of 
oxidative injury in cerebral ischemia is basal level of NAD
+
, which is depleted in oxidative- 
damaged brain (Nicotera et al., 1997).  Thus, oxidative stress dependent cell signaling events 
play a role in ischemia-induced brain damage.   
Oxidative stress is caused by the imbalance between production
 
of pro-oxidants and 
the antioxidant defenses.  Dietary and supplemental natural antioxidants, such as vitamin C 
(Henry PT, Chandy MJ, 1998) and vitamin E (van der Worp H.B. et al., 1998), reduce infarct 
size and neurological impairment after permanent ischemia or ischemia followed by 
reperfusion in rats and primates. Vitamin E prevents apoptosis due to transient ischemia in 
stroke-prone spontaneously hypertensive rats (Tagami M. et al., 1999). In addition, genetic 
manipulation of intrinsic antioxidants and factors in the signaling pathways has provided 
substantial understanding of the mechanisms involved in cell death/survival signaling 
pathways and the role of oxygen radicals in ischemic cerebral injury (Saito et al., 2005). 
In addition, there is increasing evidence that free radicals can act also by redox 
sensitive signal transduction pathways (Chan, 2001). Experimental studies suggests that free 
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radicals can induce cytochrome c release from mitochondria, which is an important step in 
the induction of apoptosis (Fujimura et al., 1999; Kim et al., 2000). Moreover, the 
contribution of oxidative stress to apoptotic cell death caused by cerebral ischemia is 
demonstrated by the efficacy of antioxidant treatment in attenuating caspase-3 activation, 
DNA fragmentation and lesion size in mice with cortical infarction (Kim et al., 2000).  Taken 
together, appears that oxidative stress signaling events may be important in ischemia-induced 
neuronal damage. 
Research interest 
In the following two chapters, we will focus on investigations into cell death 
pathways in MA-induced cell death and OGD-induced cell death respectively.  In chapter II, 
we will examine how MA induces autophagy and evaluate the role of autophagy in protein 
clearance and its association with the dysfunctional UPS.  In addition, we will address the 
role of autophagy and determine whether it is a cytoprotective or cytotoxic mechanism.  We 
will also look into the involvement of intrinsic pathway in MA-induced cell death and the 
role of PKCδ in cell signaling pathway.   
In chapter III, we will focus on the role of PKCδ in OGD-induced cell death by 
evaluating of the effects of oxidative stress on the mitochondria and downstream cell death 
signaling events.  Neuronal phenotype specificity studies will be studied to determine 
neuronal vulnerability to OGD-induced striatal neuronal injury.  
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Chapter II:  PKCδ is a key mediator of MA-induced cell death in N27 
dopaminergic neuronal cells: Role for autophagy and UPS 
A paper to be submitted to Journal of Neurochemistry 
Meng-Hsien Lin and Arthi Kanthasamy 
ABSTRACT   
Excessive oxidative stress is believed to play a pivotal role in methamphetamine (MA)-
induced dopaminergic neuronal loss.  However, the exact mechanism by which MA causes 
dopaminergic neuronal loss remains to be established.  To investigate the effects of MA on 
oxidative stress-mediated cell signaling events, we exposed N27 dopaminergic neuronal cells 
to MA (1 and 2 mM) for a period of 3, 6, 12 or 24 h. MA treatment resulted in early 
induction of autophagy (3h), followed by proteasomal dysfunction, dissipation of 
mitochondrial membrane potential, caspase-3 activation PKCδ cleavage and delayed DNA 
fragmentation.  These changes appear to be mediated via caspase-3-mediated proteolytic 
activation of PKCδ, as overexpression of cleavage resistant PKCδ mutant (CRM) effectively 
attenuated oxidative stress-mediated cell death signaling events-associated apoptotic cell 
death following MA treatment.  Furthermore, inhibition of autophagy using 3-methyladenine 
(3-MA), a phosphatidylinositol 3-phosphate kinase inhibitor, not only altered the pattern of 
LC3 distribution but also accelerated MA-induced apoptotic cell death, suggesting a 
neuroprotective role for autophagy in MA-induced neurotoxicity.  Taken together, these 
results suggest that MA-induced dopaminergic neurotoxicity is likely caused, at least in part, 
by pronounced proteolytic cleavage of PKCδ and associated oxidative cell signaling events.  
The pronounced accumulation of autophagic vacuoles may overwhelm the lysosomal 
clearance mechanism; hence resulting in neurodegeneration. Alternatively, the autophagic 
vacuoles may enable the segregation of toxic molecules from viable organelles, hence 
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limiting the spread of toxicity.  Thus, therapeutic interventions aimed at improving the 
efficiency of protein clearance system may be effective in the treatment of neurological 
disorders including PD. 
 
INTRODUCTION 
Methamphetamine (MA) is a widely used recreational drug and the usage of the drug 
is confirmed to cause both medical and neurological effects.  Chronic MA abuse leads to 
decrease in tyrosine hydroxylase (TH), depletion of dopamine (DA), loss of dopamine 
transporters and decrease in vesicular monoamine transporter proteins (Krosnova et al., 2005; 
Cadet and Bronnock, 1998; Larsen et al., 2002). All of these evidence lead to the conclusion 
that MA, a monoaminergic toxin, destroys dopaminergic neuronal terminals resulting in 
neurodegeneration (Krosnova et al., 2005).  It has been suggested that the toxic effects of 
MA may be associated with oxidative stress.  Many studies have shown MA induces 
elevation of reactive oxygen species (ROS), namely superoxide radicals and hydrogen 
peroxide, often result in pronounced DNA, lipid and protein damage (Lau et al., 2000; Cadet 
and Brannock, 1998).   
Programmed cell death can be categorized into two distinct types, the classical 
apoptotic cell death (type I) and the autophagic cell death (type II) (Bursch et al., 2005; 
Shintani and Klionsky, 2004).  Type II cell death, involved in the process of autophagy is is 
characterized by the double- membrane vesicles or multi- lamellar autophagic bodies (Maiuri 
et al., 2007).   The formation of autophagic vacuoles is described in several 
neurodegenerative disease including Parkinson’s disease and, Huntington’s disease and 
Alzheimer’s disease (Chu, 2006).   Dopaminergic neurons are shown to be prone to 
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developing autophagic stress during injury (Chu, 2006). It has been reported that MA-
induced degeneration of dopaminergic neurons involve induction of autophagy and elicit 
formation of multilamellar whorls (Larsen et al., 2002).  These characteristics are believed to 
be possible attempts of the injured cells to eliminate damaged proteins and organelles 
induced by oxidative stress.  
A characteristic feature of several neurodegenerative diseases is the dysfunction of 
ubiquitin-dependent proteasomal system (UPS) which is associated with protein aggregation 
(Strahlendorf et al., 2003; Rideout et al., 2004).  Cellular accumulation of misfolded proteins 
is a feature in inclusion bodies-related diseases, such as Parkinson’s disease, Alzheimer’s 
disease, and Huntington’s disease.  Another major system of intracellular protein degradation, 
the autophagy-lysosomal system (ALS), is involved in removal of these ubiquitinated 
inclusions and dysfunctional organelles (Rideout et al., 2004).  Impaired proteasomal system 
causes the induction of autophagy, which has been reported to be a compensatory mechanism 
believed to aid in the clearance of aggregated proteins (Komatsu et al., 2007).  In some 
studies interplay is suggested between autophagy and ubiquitin-proteasomal system 
(Komatsu et al., 2006).  However, the exact nature of this interaction remains obscure.  
Therefore, in our studies we focus on the mechanism behind MA-induced autophagy together 
with UPS in order to understand their contribution to MA-induced apoptotic cell death.  
Inductive mechanisms associated with apoptosis include extrinsic or intrinsic 
pathways.  The intrinsic pathway is described as initiated by mitochondrial release of 
proapoptotic factors proteins such as cytochrome c (Strahlendorf et al., 2003), this can be 
initiated by ROS, causing damage to the mitochondria resulting in release of mitochondrial 
cytochrome c into the cytosol (Jayanthi et al., 2004).  It has been reported that MA-nduced 
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neurodegeneration is dependent on mitochondrial dysfunction both in vivo and in vitro 
(Krosnova et al., 2005; Jayanthi et al., 2004).  Collectively, mitochondria mediated oxidative 
stress events are believed to play a crucial role in MA- induced neurodegeneration.  Less is 
known about the mechanism of MA-induced autophagy and how it is regulated in 
mammalian dopaminergic neuronal cells.   
In our studies, we evaluate another signaling pathway related to apoptotic cell death, 
involving in proteolytic cleavage of protein kinase C delta (PKCδ) by capase-3, shown 
previously by Kanthasamy et al (2006), explaining its crucial role in dopaminergic neuronal 
cell death (Latchoumycandane et al., 2005).  Protein kinase C, a family of phospholipid-
dependent serine/threonine protein kinases, plays a central role in signal transduction 
pathways and a wide variety of cellular functions, including cell proliferation, differentiation 
and cell death (Busa, 2003; Griner and Kazanietz, 2007).  PKCδ is a target of apoptotic 
stimuli, is a novel member of the PKC family, containing a regulatory domain and catalytic 
domain. PKCδ is a substrate for caspase-3, which is activated by both caspase-8, -9 and 
cleaves PKCδ at the DMQD330N site, generating a 40kDa fragment. In addition it acts as a 
positive feedback caspase-3 activator (D’Costa and Denning, 2005; Busa, 2003; Ko et al., 
2005).  Previous studies have shown that DNA damage induces cytochrome c release from 
the mitochondria, subsequently activating the PKCδ-dependent caspase-3 mediated cell death 
signaling pathway (Yang et al., 2004; Basu 2003; Ko et al., 2005).  Consistently, we have 
demonstrated the importance of caspase-3 mediated PKCδ in dopaminergic degeneration. 
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MATERIALS AND METHODS  
Cell Culture  Immortalized rat mesencephalic dopaminergic neuronal cells (N27) were 
grown in RPMI 1640 medium supplemented with 10% fetal bovine serum, 2mM L-
glutamine, 50 units penicillin and 50μg/ml streptomycin.  Cell cultures were maintained 
under 5% CO2 at 37°C as previously described (Yang et al., 2004). 
Cell Death Detection ELISA Plus Assay Kit (Roche Molecular Biochemicals, Indianapolis, 
IN) was used for the analysis of DNA fragmentation (Anantharam et al., 2002).  Briefly, cells 
were spun down at 200g for 5 min, and washed once with PBS.  Cells were then incubated 
with the lysis buffer, supplied from the kit, at room temperature.  After 30 min of incubation, 
samples were centrifuged and 20μL of the supernatants were transferred to the streptavidin-
coated 96-well plates (supplied from the kit), and 80μL of HRP-conjugated antibody cocktail 
in added to the samples.  After 2 h of incubation at room temperature with mild shaking, 
unbound components were washed with the incubation buffer supplied.  The nucleosomes 
retained by the antibody cocktail in the immunocomplex were quantified with ABTS as a 
HRP substrate. Measurements were done with SpectroMax 190 spectrophotometer 
(Molecular Devices) at 405nm and 490nm.  The difference in OD absorbance values were 
calculated and used as the actual DNA fragmentation levels.  Sample protein concentrations 
were detected with Bradford protein assay kit. 
Brain Sample Preparations and Western Blot Analysis  Western blot analysis was done as 
previously described (Sun et al., 2005).  Brain samples were lysed on ice in lysis buffer, 
containing protease inhibitors and 1%Triton X-100.  Samples were sonicated on ice for 15 
seconds and lysates were centrifuged 100,000g for 50 min.  Supernatants were collected for 
protein assay and equal amounts of proteins were separated with 10% SDS-PAGE and 
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transferred onto nitrocellulose membranes.  Standard Western blot procedure was done for 
immunoblot with overnight incubation with anti-DAT (1:250; Millipore) at 4°C and β-actin 
1:5000 (Sigma, St. Louis, MO) to confirm equal protein loading.  Membranes were washed 
several times and incubated with IR Dye 800-conjugated anti-rabbit IgG (1:5000) or Alexa 
Flour 680-conjugated anti-mouse IgG (1:10000; Molecular probes, Invitrogen) for 1 h at 
room temperature.  Membranes were scanned using the Odyssey IR Imaging system (LICOR) 
and data were analyzed with Odyssey 2.0 software.   
MDC Assay and Dual-Immunostaining  Monodansylcadaverine (MDC) is an 
autofluorescent drug which can be used as a marker for autophagolysosome.  This MDC 
assay follows Daniela et al., 2001 with some modifications.  Treated cells were incubated 
with 0.05mM MDC in PBS at 37°C for 10 min.  After incubation, cells were collected and 
lysed with 200μL of 10mM Tris-HCl, pH 8 containing 0.1% Triton X-100 for 30 min on a 
microtube shaker.  Samples were then transferred to 96-well plates and measured with 
fluorescence photometry plate reader (excitation wavelength 380nm, emission filter 525nm).  
Cells were incubated with 0.2μM ethidium bromide directly in the 96-well plate and the 
DNA fluorescence was measured (excitation wavelength 530nm, emission filter 590nm).  
MDC activity was normalized to the DNA values for comparison.   
For immunostaining, upon desired treatments time, cells plated on coverslips were incubated 
with 0.05mM MDC in PBS at 37°C for 10 min.  Samples were washed with PBS and general 
immunocytochemistry procedures are carried out.  Briefly, cells are fixed with 4% 
paraformaldehyde and blocked with 5% donkey serum.  Primary antibody, mouse anti-TH is 
incubated in 5% donkey serum at 4°C overnight.   Second day, cells were washed with PBS 
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and incubated with donkey anti-mouse for 1 hour at room temperature.  Coverslips are 
mounted on slides and examined under 60x objective with fluorescent microscope.   
Transmission Electron Microscopy  For transmission electron microscopy (TEM), cells 
grown on coverslips were fixed with 2% glutaraldehyde (w/v) and 2% paraformaldehyde 
(w/v) in 0.1M sodium cacodylate buffer, pH 7.2, for 48 h at 4°C.  Samples were washed in 
buffer and then fixed in 1% osmium tetroxide in 0.1 M cacodylate buffer for 1 hour at room 
temperature.  The samples were then dehydrated in a graded ethanol series, cleared with ultra 
pure acetone, infiltrated and embedded using a modified EPON epoxy resin (Embed 812; 
Electron Microscopy Sciences, Ft. Washington, PA).  Resin blocks were polymerized for 48 
h at 70°C.  Thick and ultrathin sections were made using a Leica UC6 ultramicrotome (Leeds 
Precision Instruments, Minneapolis, MN).  Ultrathin sections were collected onto copper 
grids and images were captured using a JEM 2100 200kV scanning and transmission electron 
microscope (Japan Electron Optic Laboratories, Peabody, MA).  
Western Blot Analysis  Treated cells were collected and lysed with RIPA buffer in ice and 
sonicated for 15 seconds on ice for each sample.  Samples were centrifuged at 100,000 g for 
40 min at 4°C.  Supernatants were collected and protein assay was done for equal loading of 
proteins.  For brain sample preparations and protein extractions from the samples please see 
experiment one for more detail.  Samples were separated on 8-15% SDS-PAGE, depending 
on the molecular weight of the target protein and transferred onto nitrocellulose membranes.  
Standard western blot procedures were performed. In brief, membranes were blocked and 
incubated with primary antibodies overnight at 4°C.  Primary antibodies used in the 
following experiments included anti-MAP-LC3-II (1:250; Abgent, San Diego CA), anti-Akt / 
anti-phospho-Akt, anti-mTOR / anti-phospho-mTOR (1:200; AbCam, Cambridge, MA), anti-
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ubiquitin (1:2000; Dakocytomation), cytochrome c (1:500; Dakocytomation). β-actin 
(1:10,000) was used for equal protein detection and Cox-4 (1:1000) was detected for 
confirmation of mitochondria fractionation.   Membranes were washed several times and 
incubated with IR Dye 800-conjugated anti-rabbit IgG (1:5000) or Alexa Flour 680-
conjugated anti-mouse IgG (1:10000; Molecular probes, Invitrogen) for 1 h at room 
temperature.  Membranes were scanned using the Odyssey IR Imaging system (LICOR) and 
data were analyzed with Odyssey 2.0 software. 
Immunocytochemistry  Dual immunostaining was done in both N27 cell cultures and 
primary cell cultures, procedures were very similar.  Briefly, cells were fixed with 4% 
paraformaldehyde after the desired treatment time.  Washing between steps were done with 
PBS, three times each.  Samples were blocked with 5% serum (either donkey or goat), 0.4% 
BSA, 0.2% TRITON x-100 for 1 hour and primary antibodies were incubated in the same 5% 
serum solution overnight at 4°C.  Primary antibodies used in the following series of 
experiments included goat anti-LC3-II (1:250; Santa Cruz), rabbit anti-ubiquitin (1:500; 
Dakocytomation), rabbit anti-LC3 (1:250), mouse anti-TH (1:1000), rabbit anti-MAP-LC3 
(1:250; Santa Cruz), goat anti-cleaved caspase-3 (1:500; Santa Cruz) and anti-lamp2 (1:300; 
Invitrogen).  Alexa Flour donkey anti-goat and donkey anti-rabbit or goat anti-rabbit and goat 
anti-mouse combinations were used for 1 h secondary antibody (1:2000) incubation.  
Hoechst staining was done for nucleus labeling and samples were then mounted on slides and 
viewed under the Nikon inverted fluorescent microscope (TE-2000U).   
Primary Mesencephalic Culture  Primary mesencephalic preparation procedures were 
followed as previously described (Yang et al., 2004).  Ventral mesencephalon was dissected 
from E14~15 day old mouse embryos, cell dissociation was done by incubating the dissected 
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tissue in trypsin-EDTA (0.25%) for 30 min.  Dissociated cells were plated on poly-D-lysine 
precoated glass cover slips in 24 well plates and incubated with 10% fetus bovine serum 
medium containing supplement B27, L-glutamine, penicillin, streptomycin and L-glutamate.  
Approximately 1 million cells were plated for each well.  Cells were maintained in 5% CO2 
at 37°C humidified environment.  10μM cytosine-arabinoside was added on the next day to 
inhibit glial cell proliferation.  Treatments were done 5~7 days post dissection.  
Proteasomal Assay  The assay was performed following Sun et al., 2006, with some 
modifications.  Briefly, cells were resuspended in buffer containing 50mM Tris–HCl, 1mM 
EDTA and 10mM EGTA, supplementing with 10μM digitonin and incubating at 37°C for 20 
min.  After incubation, lysates were centrifuged at 16,000g for 10 min.  Supernatants were 
collected and incubated with fluoregenic substrate, 75μM Suc-LLVY-AMC, for proteasomal 
activities.  After 1 hour incubation, samples were detected with fluorescence plate reader 
with wavelengths for excitation 380nm and emission 460nm (Gemini Plate Reader, 
Molecular Devices Corporation).  Enzymatic activity is expressed as fluorescence per 
micrograms of protein.   
Subcellular fractionation  Mitochondria isolation was conducted as described in Leo et al., 
1998, with some modifications.  Cells were resuspended in a homogenizing buffer containing 
250mM sucrose, pH 7.5, 20mM HEPES, 10mM KCl, 1.5mM MgCl2, 1mM EDTA, 1mM 
EGTA and protease inhibitors on ice for 30 min.  Further homogenizing was done with a 
Dounce homogenizer on ice.  Samples are centrifuged at 1000g to separate unlysed cells and 
debris.  Supernatant are centrifuged at 10,000g for 25 min, supernatants were obtained are 
cytosolic fraction and pellets are lysed in RIPA buffer for mitochondria fraction.   
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JC-1 Mitochondrial Depolarization Assay  JC-1 (Molecular probes), a cationic lipophilic 
fluorescent dye to measure mitochondria membrane potential.  JC-1 can enter the matrix of 
healthy mitochondria membrane and accumulating to express fluorescence red.  However, 
JC-1 cannot enter and accumulate in unstructured mitochondria, resulting in the green 
fluorescence seen in the cytoplasm.  The intensity of the red fluorescence in the cell can be 
an indicator of the membrane potential.  Incubation of 2μg/mL of JC-1 was used for 20 min 
of incubation with the cells at 37°C and collected.  Pellets were resuspended in 200μL of 
10mM Tris-HCl, pH 8 containing 0.1% Triton X-100 for 30 min on a microtube shaker.  
Samples were then transferred to 96-well plates and measured with fluorescence photometry 
plate reader, red and green ratio is used for indicator of mitochondrial potential.  Separate 
samples were prepared with cells grown on glass cover slips and treated with MA. Upon 
desired treatment time, cells were stained directly with JC-1 final concentration of 2μg/ml for 
20 min and mounted on slides for imaging under the fluorescent microscope.   
Kinase Assay  The enzymatic activity of PKCδ is detected using immunoprecipitation kinase 
assay as described previously (Kitazawa et al., 2003).  Treated cells were collected and lysed 
with lysis buffer containing 25mM HEPES, pH 7.5, 20mM β-glycerophosphate, 0.1mM 
sodium orthovanadate, 0.1%Triton x-100, 0.3mM NaCl, 1.5MgCl2, 0.2mM EDTA, 0.5mM 
DTT, 10mM NaF, 4μg/ml aprotinin and 4μg/ml leupeptin.  The cells lysates were centrifuged 
at 10,000g for 30 min, and supernatant was obtained for the cytosolic fraction.   500μg 
cytosolic fraction was immunoprecipitated with 2μg/ml PKCδ antibody.  Immunoprecipitates 
were washed with 2×kinase buffer and resuspend in 20μL of this same buffer. PKCδ 
phosphorylation is initiated by adding 20μL of reaction buffer (0.4mg Histone H1, 50uL/mL 
phosphatidylserine, 4.1μM dioleolglycerol, and uCi of [γ-32P]ATP) to the 
42 
 
  
immunoprecipitates. After 10 min incubation at room temperature, samples were separated 
on 12% SDS-PAGE.  Radioactive labeled histone H1 were detected using Phosphoimage 
system (Personal Molecular Imager, FX model, Bio-Rad) and analyze with Quantity One 
4.2.0 software. 
Caspase Enzymatic Activity Assay Caspase-9 and caspase-3 activity was measured using a 
specific fluorescent substrate, Ac-LEDH-AFC (caspase-9) and Ac-DEVD-AFC (caspase-3), 
as described previously (Kaul et al., 2003).  Briefly, cells were lysed with lysis buffer (50mM 
Tris HCl, 1mM EDTA, and 10mM EGTA) containing 10mM digitonin for 30 min at 37°C.  
Lysates were centrifuged at 10,000g for 5 min and cell-free supernatants were collected.  
Supernatants were incubated with fluorogenic substrate Ac-LEDH-AFC or Ac-DEVD-AFC 
for 2h at 37°C and fluorescence was measured with Gemini XS fluorescence plate reader 
(Molecular Devices) at excitation 400nm and emission at 505nm.  The measured values were 
normalized to protein concentrations from the samples with Bradford protein assay (Bio-Rad, 
Hercules, CA).   
Data Analysis and Statistics All data analysis was first performed with InStat 3.0 
(GraphPad software, San Diego) and then graphed with Prism 4.0 software.  One-way 
ANOVA was used for multiple comparisons and single comparisons were done using the 
Student’s t-test.  Student Newman Keuls was used for post analysis.  *p<0.05 was considered 
as significant difference.  
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RESULTS 
MA induces apoptotic cell death in N27 dopaminergic cells 
Previous studies have demonstrated the occurrence of MA-induced cell death in 
several cell lines (Seilden et al., 1987; Cadet et al., 1998; Krasnova et al., 2005).  In the 
present study we investigated the optimal dose that is necessary to elicit an apoptotic 
response.  To this end, we performed dose response cytotoxicity analysis.  A dose-dependent 
decrease in cell viability (Fig. 1), as assessed by DNA fragmentation analysis, was observed 
in N27 cells exposed to increasing concentrations of MA.  Following exposure to 0.1, 0.3, 1, 
3 mM MA for 24 h, the cell viability was decreased by 25, 32, 47 and 57% respectively, as 
compared with control.  An EC50 of 1.39 mM was deduced by nonlinear regression.  In the 
subsequent set of experiments, we used the following concentrations of MA, namely 1 and 2 
mM to determine its ability to elicit an autophagic and apoptotic response. 
 
Activation of autophagy by MA  
 Careful examination of MA-treated cells under a light microscope revealed the time-
dependent accumulation of microscopic vacuoles, which was evidenced as early as 3 h post 
treatment and peaked at 12-24 h post drug treatment (Fig. 2A).  The number and size of the 
vacuoles increased in a time- and dose-dependent  manner in MA-treated cells (Fig. 2A).  
However, vacuoles were hardly visible in control cells treated with phosphor-buffered saline 
(PBS).  The dose-dependent effect of MA on the induction of autophagic vacuoles were 
further quantified by fluorescence microscopy.   For this purpose, we used monodansyl 
cadaverine (MDC), a dye most frequently used for the quantification of acidic vacuoles.  
Exposure to 1 and 2 mM MA resulted in a 1.25- to 2- fold increase in MDC fluorescence 
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from 3 to 24 h (Fig. 2A), suggesting that MA induces up-regulation of autophagic vacuoles 
(AV) in dopaminergic neuronal cells.  Based upon these results, dual staining for TH and 
AVs were performed in MA treated primary dopaminergic neurons to confirm and extend 
our findings in N27 cells (Fig. 2B).  Treatment of primary midbrain mesencephalic neurons 
with 0.5 mM MA for 24 h resulted in neuritic shortening and punctate appearance of MDC 
positive structures in TH-positive neurons as compared with control cells where a diffuse 
distribution was evidenced.  Furthermore, transmission electron microscopy (TEM) was 
utilized to obtain ultrastructural details of the AVs at 24 h post MA treatment.  Majority of 
these vacuoles demonstrated close resemblance to AVs characterized by a double membrane 
structure enclosing partial digested organelles such as mitochondria and cytoplasmic contents.  
The magnitude of vesicular accumulation was much higher in MA –treated cells as compared 
with control cells.  The following data indicate that MA induces a time-dependent increase in 
autophagic vacuoles in N27 dopaminergic cells. 
 
MA induces LC-II accumulation 
To further determine and quantify MA-induced autophagy in dopaminergic neurons, 
a common autophagy associated protein, light chain microtubule-associated protein (LC3-II), 
was determined by immunoblot analysis. LC3 has been shown to exist in two forms.  LC3-I 
that resides in the cytoplasm is post translationally modified into membrane-bound LC3-II, 
that becomes an integral component of autophagosomes during induction of autophagy 
(Yang et al., 2005).  Immunoblot analysis of proteins obtained from MA (1 and 2 mM) 
treated N27 cells revealed a time- and concentration- dependent increase in LC3-II levels 
(Fig. 3A).  Weak bands corresponding to LC3LI were found in control cells.   
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Next, to determine the extent of LC3 redistribution mediated by MA, 
immunofluorescence microscopic examinations were performed at 24 h to trace the 
redistribution to autophagic compartments.  In the control treated cells, LC3 exhibited diffuse 
green fluorescence in the cytoplasm, whereas in 2 mM MA-treated cells a characteristic 
punctuate pattern of distribution were evidenced, indicating the translocation to 
autophagosomal membranes.  The number of MA-treated cells with punctate pattern of 
distribution further confirms MA-induced autophagic induction (Fig. 3B). 
Primary mouse mesencephalic cultures were treated with 0.5 mM MA for 24 h using 
a dose that caused selective injury to dopaminergic neurons (Larsen et al., 2002).  Double 
immunolabeling studies using TH and LC3 showed that MA elicited a granular pattern of 
staining in MA –treated primary mouse mesencephalic cultures. 
 
MA treatment promotes dissipation of mitochondrial membrane potential (MMP) and 
release of mitochondrial cytochrome c release  
 In recent years, disruption of mitochondrial function has been shown to be a critical 
trigger in the induction of autophagy and the subsequent removal of damaged mitochondria 
(Elmore et al., 2001; Sansanwal et al., 2010).  Furthermore, mitochondrial pathway has been 
shown to play a significant role in regulating MA-induced cell death (Krosnova et al., 2005; 
Jayanthi et al., 2004).  To investigate the potential role of mitochondrial dysfunction in MA-
induced neurodegeneration, we determined alteration of MMP and cytochrome c release in 
MA-treated N27 cells.  Cells were incubated with JC-1, a lipophilic cationic dye that is 
routinely used to measure MMP.  As shown in Fig. 4A, examination of vehicle treated 
control by fluorescence microscopy revealed bright orange punctate staining in the 
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cytoplasmic regions, consistent with the formation of JC-1 “J-aggregates” characteristic of 
actively respiring mitochondria.  MA (2mM) produced a dramatic reduction in the intensity 
of orange red spots and predominance of green staining consistent with loss of MMP.  
Analysis of MMP by spectrometric pate reader analysis revealed a dose- and time- dependent 
decrease in MMP, evidenced as early as 2 h, with a ~50% reduction in MMP over a 12 h 
period post MA treatment (Fig. 4B).  Furthermore, several lines of evidence have recently 
shown that exposure to dopaminergic neurotoxins result in altered MMP that is accompanied 
by release of proapoptotic factors including cytochrome c and smac/DIABLO in the cytosol 
(Kitazawa et al., 2001; Kaul et al., 2003) to initiate the apoptotic cascade.  In the present 
study, treatment of N27 cells with increasing doses of MA (0.5 – 2 mM) resulted in increased 
levels of cytosolic cytochrome c as compared with control (Fig. 4C).  In MA treatment, 
cytosolic cytochrome c levels by 400% and 1200%  at 12 and 24 h respectively as compared 
with control. 
 
MA-induces a dose- and time- dependent increase in caspase-3 activation 
 It is well known that cytosolic cytochrome c release is an upstream activator of 
multiple caspases, including caspase-9 and -3 (Kanthasamy et al., 2003; Latchoumycandane 
et al., 2005).  Caspase-3 represents the ultimate cell death execution step in both neuronal 
and non-neuronal cells.  In the present study, we examined the effect of MA on capase-3 
activation in N27 cells.  Treatment of N27 cells with MA resulted in time- and dose- 
dependent increase in caspase-3 activation as compared with control.  MA treatment (1 and 2 
mM) resulted in 250% and 400% increases at 12 h; 320% and 430% increases at 24 h, 
respectively as compared to control treated groups.  
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Modulation of PKCδ activation involved in MA-induced apoptosis and autophagy 
Recently, activated caspase-3 was found to cleave PKCδ, yielding a 38-kDa 
regulatory fragment and a 41-kDa catalytic fragment that leads to persistent activation of 
PKCδ kinase activity.  Exposure to MA (0.5 – 2mM) for 24 h led to a dramatic increase 
(175-200%) in the magnitude of catalytic and regulatory fragments, suggesting that MA-
induces PKCδ activation (Fig. 6A). Similarly, a parallel increase in PKCδ kinase activity was 
evidenced (Fig. 6B).  In fact, treatment of N27 cells for 24 h with 2 mM MA resulted in 
increased kinase activity as compared to control.  To determine the exact contribution of 
PKCδ in MA-induced neurotoxicity, we overexpressed a kinase inactive dominant negative 
(DN) mutant (PKCδK376R) in N27 cells and subsequently exposed to MA.  Exposure to 2mM 
MA resulted in a five-fold increase in DNA fragmentation in control cells expressing the 
empty vector.  However, the response was attenuated in N27 cells stably expressing the 
PKCδ-DN mutant.  Additionally, we tested the importance of proteolytic cleavage of PKCδ 
in MA-induced neurotoxicity by evaluating the effects of overexpression of cleavage 
resistant PKCδ kinase (PKCδD327A-CRM).  N27 cells expressing Lac-Z was used as control.  
As shown in Fig 6D, MA-induced proteolytic cleavage of PKCδ was almost completely 
attenuated in PKCδD327A-CRM.   Furthermore, 2mM MA-induced DNA fragmentation was 
completely abrogated in CRM cells, while three-fold increase in DNA fragmentation was 
observed in Lac-Z-expressing cells as compared with PBS treated control cells (Fig. 6E).  
Additionally, we determined whether MA-induces caspase-3 activation despite attenuation of 
apoptotic response.  Spectrofluorometric plate reader avalysis of caspase-3 activity in MA-
treated CRM cells showed that caspase-3 activation was significantly reduced (ns) in 1 and 2 
mM MA-treated CRM cells at 6, 12 and 24 h respectively, as compared with empty vector 
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expressing N27 cells (Fig. 6F).  To investigate the role of PKCδ in MA-induced autophagy, 
we studied the ultrastructural details in MA (2mM) –treated cells at 24 h using TEM.  An 
increased accumulation of nascent or pre-autophagic vacuoles were evidenced in the 
cytoplasm of MA-treated CRM cells (Fig. 6G).  Conversely, a large increase in AVs 
containing undigested cytoplasmic materials were observed in vector overexpressing N27 
cells, underscoring the importance of PKCδ activation in both apoptotic cell death and 
autophagic processes. 
 
MA induces loss of proteasomal function and promotes accumulation of ubiquitin-positive 
aggregates and colocalization with autophagic vacuoles 
 Several studies have shown the dysfunction of UPS may contributr to neuronal 
degeneration disease, such as Parkinson’s disease (PD) and activation of autophagy 
(Strahlendorf et al., 2003; Rideout et al., 2004; Komatsu et al., 2006).  In this set of 
experiments, the status of the UPS and the extent if cross talk with autophagy were evaluated.  
MA (1 and 2mM) decreased proteasomal activity in N27 cells in a dose- and time- dependent 
manner (Fig. 7A).  Inhibition of proteasomal activity coincided with upregulation of 
autophagy suggesting that autophagy may serve as a compensatory response to replenish 
proteasomal dysfunction.  Also, MA increased ubiquitination in a dose- and time- dependent 
manner (Fig. 7B).  Moreover, ubiquitin-like immunoreactivity in MA (2mM)-treated cells 
accumulated as large aggregates that colocalized with LC3 (Fig. 7B).  From these findings, 
we conclude that early proteasomal dysfunction triggers accumulation of ubiquitin-positive 
aggregates and presumably promote autophagy-mediated degradative machinery. 
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Defective clearance of autophagic vacuoles (AVs) in MA-treated N27 cells 
 An important function of autophagy is to facilitate protein disposal system via 
lysosomal clearance pathway.  This is mediated by the fusion of autophagosomes and 
lysosomes during the later phase of autophagy.  Dysfunction in the fusion process might 
overload the lysosomal clearance system, hence, resulting in accumulation of undigested 
cytoplasmic material and ultimately resulting in death.  To test whether the LC3 labeled 
autophagosomes are efficiently transported to lysosomes, N27 and PKCδ-CRM cells were 
treated with MA (2mM), stained with LC3 and lysosome associated membrane protein 
(LAMP-2), lysosomal marker protein, and analyzed by confocal microscopy.  Colocalization 
studies revealed that N27 cells exposed to MA (2mM), only a small portion of LC3-positive 
autophagosomes merged with LAMP-2-positive lysosomes whereas in PKCδ-CRM cells, a 
complete overlap of the ALS markers were evidenced, suggesting an efficient lysosomal 
clearance system in MA-treated PKCδ-CRM cells.  The following studies suggest a putative 
negative regulatory effects of PKCδ on the ALS in MA-induced neurotoxicity in N27 cells. 
 
Inhibition of autophagy increases the sensitivity of N27 cells to MA-induced apoptotic cell 
death  
We investigated the possible link between autophagy and apoptotic cell death in MA-
treated N27 cells.  In the effort to determine the role of autophagy in MA-induced neuronal 
cell death, we used 3-methyladenine (3-MA), an autophagy inhibitor.  Pretreatment with 3-
MA (1mM) promoted MA-induced DNA fragmentation.   As shown in Fig. 9A, 3-MA 
pretreatment results in 2.5-fold increase in MA-induced DNA fragmentation when compared 
with control treated cells.  Taken together, these findings suggested that MA-induced 
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apoptotic cell death was potentiated by 3-MA and that the autophagy mediated by MA may 
be cytoprotective by nature. 
 
MA-induced modulation of autophagy, UPS and PKCδ in vivo 
To further evaluate the participation of autophagy, UPS and PKCδ in MA-induced 
striatal neurodegeneration in vivo, the present study assessed levels of  LC3, ubiquitin, PKCδ 
in striatal tissues harvested from MA-treated rat (4 x 20mg/kg every 2 h).  Consistent with 
our in vitro findings, the present data show that MA-induced upregulation of autophagy, 
ubiquitin and PKCδ cleavage at 24 h post drug treatment (Fig. 10).  To further examine 
whether MA-induced delayed upregulation of autophagosomal, ubiquitin and PKCδ markers, 
the current study assessed the cumulative accumulation of the above mentioned markers at 1 
week after MA treatment.  The results showed that MA-induced autophagy, ubiquitin 
accumulation and PKCδ cleavage in the striatum although the magnitude of upregulation of 
markers were not significantly different from 24 h MA-treated striatal tissue. 
 
DISCUSSION 
This study demonstrates the occurrence of apoptotic cell death as evidenced by an 
increase in DNA fragmentation levels in an in vitro N27 dopaminergic cell culture model of 
dopaminergic neurodegeneration following MA treatment.  Furthermore, along with cell 
death a dramatic increase in the accumulation of autophagosomes in the cytoplasm were 
evidenced in MA-treated cells.  Interestingly, the upregulation of autophagosomes also 
positively correlated with increased levels of ubiquitinated proteins which suggest a putative 
crosstalk between the two major protein degradation systems, namely ubiquitin-proteasomal 
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system (UPS) and autophagy-lysosomal system (ALS).  In this context, our studies revealed 
that inhibition of autophagic activity enhances MA-induced apoptotic cell death which 
suggests a cytoprotective role for autophagy, at least in N27 dopaminergic neuronal cells 
exposed to MA.  Furthermore, PKCδ-mediated event appears to play a critical role in MA-
induced neurodegeneration. 
Recent studies from our lab showed that PKCδ, a member of novel PKCs, plays a 
proapoptotic role in various cell types (Kanthasamy et al, 2003).  We also showed that PKCδ 
is an oxidative stress kinase in response to demise stresses (Kanthasamy et al., 2003; Kaul et 
al., 2005).  Oxidative stress and apoptotic in cell death have been implicated in several 
neurodegenerative diseases, including Parkinson’s disease (PD).  Recently Krosnova et al., 
2001 demonstrated that MA -induced neurotoxicity is also associated with the production of 
hydroxyl and superoxide radicals which highlights the importance of oxidative stress 
mechanisms in dopaminergic neurodegeneration.  Previously, we showed that oxidative 
stress in dopaminergic neuronal models persistently activates PKCδ by proteolysis via 
caspase-3 cleavage, which yields a 41-kDa catalytically active fragment and a 38-kda 
regulatory fragment (Anantharam et al., 2002).  In addition, the proteolytic activation of 
PKCδ was found to contribute to apoptotic cell death in cell cultures models of PD (Kaul et 
al., 2003; Yang et al., 2004).  Likewise, we observed that caspase-3 dependent PKCδ 
cleavage was associated with cell death in MA-treated dopaminergic neuronal cells.  
Interestingly, concurrent LC3-II accumulation and activation of PKCδ was observed in MA-
treated cells which may imply that PKCδ might exert regulatory effects on autophagic 
induction.  A recent model proposed by Chen et al., 2009, provides evidence that 
PKCδ/JNK1 signaling mechanism mediates a disassociation of Bcl-2 and Beclin 1, hence 
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resulting in autophagy. However, as hypoxic stress sustains, proteolytic activation of PKCδ 
and caspase-3, the protection afforded by autophagy is compromised; and hence commits the 
cell to undergo apoptosis (Chen et al., 2009).  At the present time, the molecular mechanisms 
underlying PKCδ and autophagy cross talk is unclear, it warrants further investigation. 
Despite the critical contribution of caspase-3 dependent proteolytic cleavage of PKCδ 
in MA-induced dopaminergic neurodegeneration, the signaling pathways that regulate PKCδ 
activation remains obscure.  The events upstream of caspase-3 activation in MA-induced 
apoptotic cell death involve via a deregulation of mitochondrial signaling cascade that 
promote cytochrome c release.  Mitochondrion plays an important role in metabolism and 
cell survival/ death decisions.  In addition, neurons are especially dependent upon normal 
mitochondrial function to support the cells’ high energy demands.  This is reflected in 
neurodegenerative diseases including - Huntington’s, Parkinson’s and Alzheimer’s disease - 
whereby mitochondrial dysfunction and disruption of mitochondrial dynamics have been 
implicated in the disease pathology (Casarrino and Bennett, 1999).  The mitochondria are 
major sites of oxidative phosphorylation in the cell.  These respiration activities produce 
reactive oxygen species (ROS) which can promote cytotoxicity and cell death (Kim et al., 
2007).  As a major source of ROS, mitochondria are especially prone to ROS damage, 
inducing mitochondrial permeability transition caused by opening of the pores in 
mitochondrial inner membrane.  Such depolarization of mitochondrial membrane potential 
leads to the release of apoptotic factors and therefore, serves as a prelude to apoptotic cell 
death.  The current JC-1 results reflect early mitochondrial membrane depolarization at 2-3 h 
of MA treatment (Fig. 4), which triggers the mitochondria to release apoptotic factors, 
resulting in caspase-3 activation and PKCδ cleavage.  In addition, ultrastructural evidence of 
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mitochondrial disruption/dysfunction is presented in TEM images (Fig. 6G), namely, 
damaged mitochondria showing mitochondrial swelling and loss of cristae that is enclosed 
within double membrane vesicles, inductive of mitophagy in 2mM MA-treated N27 cells at 
24 h.  Mitochondrial quality control is maintained through mitophagy.  Mitophagy is a 
process by which mitochondrial turnover is carried out though autophagic sequestration and 
delivery to lysosomes for hydrolytic degradation.  This timely elimination of aged and 
dysfunctional mitochondria are essential in cell survival in terms protection of cells from 
harm caused by disordered mitochondrial metabolism and prevention of proapoptotic protein 
release.  Emerging evidence suggest that this process is not random but a selective process 
(Chen and Chang, 2009).  Recently Narendra et al., 2008 demonstrated that Parkin is one of 
the proteins suspected to act as a sensor for the trigger of mitophagy, thereby facilitating the 
degradation of effected organelles. Together, these studies support the idea that modulation 
of mitochondria depolarization may be a suitable therapeutic target to minimize MA-induced 
cell death. 
Parallel to the autophagy-lysosomal system (ALS), is the ubiquitin-proteasomal 
system (UPS). Majority of the intracellular proteins and misfolded proteins are degraded by 
the UPS, while some long-lived proteins and damaged organelles are degraded by ALS.  
We hypothesize that UPS dysfunction may contribute to neurotoxicity and result in cell 
death.  In support of this hypothesis, we demonstrate the accumulation of ubiquitinated 
proteins in MA-induced cell death at 12 h, which is preceded by downregulation of 
proteasome activity as early as 3 h following MA treatment (Fig. 7).  Interestingly, cell 
death is attenuated in CRM (caspase-3 cleavage inhibited cells) in association with dramatic 
reduction in ubiquitin positive protein aggregates.  The modulatory effects of PKCδ-CRM 
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cells on clearance of ubiquitinated proteins together with restoration of proteasomal activity 
to control levels suggests that PKCδ activation in N27 cells may contribute to the 
impairment of UPS.  Recent studies suggest that proteasomal inhibition facilitates the 
induction of autophagy, suggesting that the two mechanisms are functionally coupled (Ding 
et al., 2007; Kouroku et al., 2007).  UPS is important for degradation of misfolded proteins 
exported from endoplasmic reticulum (ER), when UPS is suppressed and misfolded proteins 
build up.  However, when proteasomal function is deregulated, autophagy is activated to 
compensate for the reduced proteasomal function.  Although the two systems target 
different proteins, while UPS degrades short-lived proteins and ALS degrades long-lived 
proteins, both serve a similar purpose of degrading proteins for energy reutilization.  In our 
model, both systems are evaluated in terms of their activation under MA-induced 
mitochondrial stress environments.  Accumulation of ubiquitinated proteins in MA-treated 
cells and down regulation of both UPS and autophagy in MA-treated N27 cells (Fig. 7C), 
may suggest that disruption of protein degradation machinery may be a causative factor in 
MA-induced neurodegeneration. 
In conclusion, the present study shows that MA-induced autophagy and apoptosis in 
N27 cells is associated with UPS dysfunction and impairment of mitochondrial function.  
Furthermore, this process is regulated by proteolytic cleavage of PKCδ, and is involved in 
the induction of mitochondrial proapoptotic cell signaling events. The beneficial effect of 
improved autophagy coupled with improved lysosomal clearance may be useful in limiting 
MA-induced dopaminergic neurotoxicity. 
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FIGURE 1. 
 
  
 
 
 
 
 
 
Figure 1.  Methamphetamine (MA) induced neurotoxicity in N27 mesencephalic 
dopaminergic neuronal cells.  DNA fragmentation assay was performed in N27 
dopaminergic cells treated with 0.1 to 3mM MA for 24 h to measure cell death.  Data 
represents results from six individual measurements.  
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C     N27 cells- untreated (control) 
 
 
 
 
 
 
 
         N27 cells- 2mM MA (24 h) 
 
 
 
 
 
 
 
Figure 2.  MA induces autophagic vacuoles (AV) in N27 dopaminergic neurons.  A,  N27 
cells were treated for 3, 6,12 and 24 h with 1mM and 2mM MA and induction of AVs was 
observed under 40x microscopic objective.  MDC staining was used for AV quantification 
and experiment details are depicted in methods section. NH4Cl was used for positive control.  
MDC values represent mean +/- S.E.M. from at least six individual measurements. Asterisks 
(*p<0.05, **p<0.01, p***<0.001) indicate significant difference compared with control 
neurons.  B, Dual immunostaining was done in MA (0.5mM)-treated primary striatal neurons 
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at 24 h for MDC and TH detection and compared with control neurons.  Samples were 
observed with a Nikon TC2000 fluorescent microscope under the 60x oil objective.  C, TEM 
studies were done to examine 2mM MA-treated N27 cells at a higher magnification.   Red 
arrow identifies the healthy nucleus of an untreated N27 cell; blue arrow points to several 
healthy and functioning mitochondria, characterized by the intact mitochondrial cristae.  The 
rigid borders of the cell represent processes spreading out from a healthy cell.  In the 
MA(2mM)-treated cell, yellow arrows point to several AVs in the cytoplasm, some filled 
with particles and organelle-like structures.  The border of this treated cell is less rigid and 
more rounded.  
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FIGURE 3. 
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Figure 3.    LC-II is associated with the formation of autophagy in MA-treated neurons.  
A, Immunoblot analysis was performed to detect for LC3-II expression in MA (1 and 2 mM) 
-treated N27 cells at 12 and 24 h and compared to control neurons.  Procedures are detailed 
in the methods section. Blots show LC3-I (18kDa) and LC3-II (16kDa) bands. β-actin was 
probed for equal protein loading.  B, Immunocytochemistry staining for LC3 was performed 
in MA (2mM)-treated N27 cells at 24 h and compared with control neurons. C, Dual 
immunostaining was done in 0.5mM MA-treated primary mesencephalic neurons 24 h.  TH- 
positive neurons were detected along with LC3-II and compared to control cells.  In both 
experiments, cells were viewed under a Nikon TE2000 fluorescence microscope with 60x 
magnification.  
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FIGURE 4. 
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Figure 4.  Mitochondrial pathway is involved in MA-induced apoptotic cell death in N27 
cells.  A, JC-1 staining, which detects MMP activity, was performed in 2mM MA-treated 
N27 cells at 1 and 2 h, and compared to control cells.  Procedures are described in methods 
section.  Images were immediately taken with a Nikon TC200 fluorescence microscope 
under 60x objective.  B, JC-1 staining was done in 1 and 2 mM MA-treated N27 cells and 
fluorescence activity was measured at 3 and 12 h, and compared to control neurons.  40μM 
CCCP induces mitochondrial membrane depolarization and was used for positive control.  
Results represent mean +/- S.E.M. of six individual measurements.  Asterisks (*p<0.05, 
**p<0.01 and ***p<0.001) indicate significant difference compared with control group.  C, 
Immunoblot analysis was performed for detection of cytochrome c (15kDa) release into 
cytosolic fraction in 0.5, 1 and 2 mM MA-treated N27 cells at 12 and 24 h.  Cox-4 antibody 
was used for labeling mitochondrial fraction and β-actin was probed for equal protein loading.  
Duplicates were shown for each treatment.  Asterisks (*p<0.05, **p<0.01) indicate 
significant difference compared with control group. 
67 
 
  
FIGURE 5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.  MA induces caspase-3 activity in N27 neuronal cells.  Caspase-3 activity was 
detected in 0.5, 1 and 2mM MA-treated N27 cells at 6, 12 and 24 h.  Experimental 
procedures are detailed in the methods section. Data represent mean +/- S.E.M. of six 
individual measurements. Asterisks (***p<0.001) indicate significant difference compared to 
control neurons. 
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FIGURE 6. 
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       (b)   CRM cells- untreated (control) 
 
 
 
 
 
 
 
CRM cells- 2mM MA  (24 h) 
 
Figure 6.  PKCδ is a potential regulator in MA-induced cell death.  A, Immunoblot 
studies were performed in MA (0.5, 1 and 2 mM) -treated N27 cells at 24 h and compared to 
control neurons.  Cleaved PKCδ (41 kDa) was detected and β-actin was reprobed for equal 
protein loading.  Duplicate bands are shown.  B, PKCδ activity was measured through kinase 
assay in MA (1 and 2 mM) -treated N27 cells at 24 h and compared to control sample.  
Phosphorylated histone bands are shown.  C, DNA fragmentation activity was detected for 
cell death determination in MA (1 and 2 mM) -treated dominant negative (DN) N27 kinase 
activity inactivated cells (PKCδ K376R) at 24 h.  Values represent mean +/- S.E.M. from at 
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least six individual measurements.  Asterisks (*p<0.05 and p***<0.001) indicate significant 
difference compared with control group and ns represents non-significant compared to 
control.  D, E, F, Confirmation of PKCδ activity, DNA fragmentation and caspase-3 activity 
was detected in MA (1 and 2mM) -treated caspase-3 cleavage resistant mutant PKCδD327A 
(PKCδ-CRM) cells. PKCδ activity was determined via western blot detection of cleaved 
PKCδ (41 kDa) in PKCδ-CRM cells (D) and compared to results in N27 cells (A).  β-actin is 
reprobed for equal protein loading.  DNA fragmentation activity was detected in MA-treated 
PKCδ-CRM cells and compared with N27 cells (E). Caspase-3 activity was detected in MA -
treated PKCδ-CRM at 6, 12 and 24 h and compared to N27 cells.  Data represent mean +/- 
S.E.M. of six individual measurements. Asterisks (*p<0.05, **p<0.01 and p***<0.001) 
indicate significant difference compared with control group and ns represents non-significant 
compared to control. G, TEM studies show cellular morphology at a higher magnification in 
2mM MA-treated N27 (a) and PKCδ-CRM (b) cells compared to control cells.  Red arrow 
shows a healthy nucleus in N27-untreated cell; green arrow identify a swollen and 
disruptured mitochondrion revealing loss of cristae structure in MA-treated cell; yellow 
arrow shows AVs filled with disorganized and undigested organelles.  Whereas in MA-
treated PKCδ-CRM cells, numerous cup shaped structures representing preautophagosomes 
(purple boxes) are distributed in the cytoplasm.  Middle pictures shows higher magnification 
of the cup shaped structures.  AVs in the cytoplasm of the MA-treated PKCδ-CRM cells 
(pink arrows), reveals less disorganized particles compared those in N27 cells.   
 
 
 
 
 
 
73 
 
  
FIGURE 7. 
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Figure 7.  MA induces accumulation of ubiquitin-conjugated proteins and 
downregulates proteasomal activity in MA-treated N27.  A, Proteasome activity was 
detected in 1 and 2 mM MA-treated N27 cells (a) and PKCδ-CRM cells (b) at 2 to 18 h.   
5μM MG-132 was used for positive control to inhibit proteasomal activity.  Results represent 
mean +/- S.E.M. of six individual measurements.  Asterisks (***p<0.001) indicate 
significant difference compared to control group.  B, Immunoblot analysis was performed to 
detect for ubiquitin aggregated proteins (250~50 kDa) in MA (1 and 2 mM) -treated N27 and 
PKCδ-CRM cells at 12 and 24 h, and compared to control group.  C, Dual immunostaining 
was performed to detect for LC3 and ubiquitin in 2mM MA-treated N27 cells and compared 
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with PKCδ-CRM cells at 24 h.  Neurons were viewed under 60x objective with a Nikon 
TC2000 fluorescence microscope as described in methods sections.  
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FIGURE 8. 
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Figure 8.  Dysfunctional autolysosomal fusion results in MA-induced apoptosis.   
Dual immunolabeling detected for LAMP-2 and LC3 in 1mM and 2mM MA-treated N27 
cells (a) and PKCδ-CRM cells (b) to reveal the relationship between lysosome and autophagy 
respectively.  Results were compared between N27 and PKCδ-CRM cells.  Cells were 
viewed under 60x with a Nikon TC2000 fluorescence microscope as described in methods 
section. 
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FIGURE 9. 
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Figure 9.  DNA fragmentation levels increase in 3-methyladenine (3-MA) pretreated 
N27 cells.  A, DNA fragmentation assay is performed to reveal cell death levels in 3-MA (1 
or 5mM) -pretreated N27 cells followed by MA (1and 2 mM) treatment for 24 h.  Values 
represent mean+/- S.E.M. from six individual measurements. Asterisks (*p<0.05, **p<0.01) 
indicate significant difference compared to control neurons.  B, Dual immunolabeling 
detected LC3 and ubiquitin in 3-MA (1mM) -pretreated N27 cells followed by MA (1 or 2 
mM) treatment at 12 and 24 h (b) compared to MA-treated only group (a).   Cells were 
viewed under 60x oil objective with a Nikon TC2000 fluorescence microscope. 
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FIGURE 10. 
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Figure 10.  MA induces autophagic cell death in vivo studies.   Western blot analyses were 
done in MA-treated rodent brain samples, treated with MA (4x20mg/kg) for either 24 h or 
1week.  A, LC3-II (16 kDa); B, Ubiquitinated aggregation (250~50 kDa); C, Cleaved PKCδ 
(41 kDa); D, DAT (55kDa) protein expression was detected in MA-treated tissue and 
compared with the control group as described in the method section. β-actin was probed for 
equal protein loading. 
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Chapter III:  Proteolytic activation of PKCδ is involved in neuronal death 
after OGD in mouse primary striatal cultures 
A paper to be submitted to Journal of Neurochemistry 
Meng-Hsien Lin and Arthi Kanthasamy 
ABSTRACT 
Stroke is the third leading cause of morbidity and mortality in the US, yet effective 
therapeutic interventions for the treatment of ischemia-induced brain damage are limited.  
The majority of the oxidative stress-related neurodegenerative studies in ischemic research 
have focused on either cortical or hippocampal regions; however, the cellular mechanisms 
underlying ischemic damage to the striatum, a dopamine enriched brain region that is highly 
susceptible to oxidative damage, remains poorly understood.  Although the role of oxidative 
stress in apoptotic cell death is well characterized, the downstream executioner events that 
lead to DNA fragmentation following caspase-3 activation are currently not well established.  
In the present study, we have identified that PKCδ, a member of the novel PKC isoform 
family and an oxidative stress kinase, is highly expressed in striatal neurons.  Primary mouse 
striatal neurons were subjected to oxygen-glucose deprivation (OGD) for 2 h and then 
incubated in normoxic conditions for 12 and 24 h.  OGD-induced a significant increase in 
caspase-3 activity in striatal neurons within 12 h, followed by proteolytic cleavage of PKCδ, 
leading to persistent activity of PKCδ.  This was accompanied by a persistent increase in 
PKCδ kinase activity, which was effectively blocked in genetically PKCδ knockdown mice 
(PKCδ-KO).  Importantly, PKCδ-KO primary striatal neurons conferred resistance to OGD-
induced neuronal injury.  Together, these results demonstrate that caspase-3-dependent 
proteolytic activation of PKCδ is a master regulator of cell death in striatal neurons during 
ischemia-induced neuronal injury. 
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INTRODUCTION 
Stroke occurs when the oxygen supply to the brain is interrupted by blockage or rupture 
of the blood vessels.  The lack of oxygen to the brain causes brain cells to die and results in 
symptoms such as paralysis, speech impairment, inability to understand and other damages to 
the brain.  Stroke kills nearly 150,000 people in the United States alone annually and is the 
leading cause of adult disability.  Despite recent medical and surgical advances, e.g. 
antiplatelet agents, anticoagulant therapy, carotid endarterectomy, bypass surgery and 
endovascular treatment, the general approach to preventing acute ischemic brain damage 
resulting in irreversible cerebral infarction remains inadequate.  This study focuses on 
mechanisms related to ischemic insult-induced delayed neuronal death, and also to identify 
certain types of neurons that are especially vulnerable to ischemic stress. 
The striatum ischemia has been known for its susceptibility to cerebral ischemia in 
animal models of cerebral ischemia (Yang et al., 1998).  Research has focused on finding the 
cause of such vulnerability to ischemia in the striatal neurons.  Several studies concluded that 
the innervations of NMDA receptors in these neurons plays a role in accumulation of 
glutamate and increases the susceptibility of stroke damage in striatal ischemia (Yang et al., 
1998; Ghibri et al., 1994).  Another widely discussed receptor is the GABA receptors that 
have been shown to mediate striatal ischemia (Centonze et al., 2001). Large aspiny neurons 
are the only non-GABAergic neurons in the striatum. After transient cerebral ischemia, large 
aspiny neurons survive while medium aspiny neurons die. Previous studies have shown that 
differential changes in the intrinsic membrane properties and excitatory synaptic transmission 
play a role in this selective vulnerability. However, the role of inhibitory synaptic 
transmission in this selective vulnerability is still unknown.  A growing body of literature 
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suggests that PKCδ is involved in apoptotic pathway observed in delayed cerebral 
reperfusion injury and other damage after stroke (Lipton et al., 1999).  Evidence such as 
increased PKCδ mRNA and protein levels are reported in the cortex and hippocampus after 
ischemia insult (Miettinen et al., 1996; Koponen et al., 2000).  Bright et al., showed the 
involvement of PKCδ in ischemic and reperfusion damage produced in the hippocampus 
region (Bright et al., 2004).  They used Δv1-1, a specific PKCδ inhibitor, to demonstrate 
reduced cellular injury and cerebral tissue damage in both in vivo transient focal ischemia 
model and in vitro hippocampal slice culture model respectively.   The present study 
provides evidence for the involvement of PKCδ in striatal cell death using OGD model of 
ischemia.  It has helped us to provide an explanation for the selective vulnerability of 
striatum to OGD –induced apoptotic cell death. 
 
MATERIALS AND METHODS 
Primary Striatal Neuronal Culture  Tissue was dissected from the striatum region of E17 
PKCδ +/+ and PKCδ -/- mice embryos and digested with trypsin-EDTA for 30 min by 
incubation 37°C water bath.  Dissociated cells were counted and plated on poly-D-lysine 
(1mg/ml) precoated cover glass at a density of 1.6 million cells per well in 6-well plates or 
0.5 million cells per well in 24-well plates.  Primary neuronal culture medium contained B27 
supplement, L-glutamine (500μM), L-glutamate (25μM), penicillin/streptomycin (100μg/ml).  
Cells were maintained at a humidified environment containing 5% CO2 at 37°C.  Cytosine 
arabinoside (10 μM) were treated for 12 h to reduce glial cell proliferation two days after 
surgery.  Experiments were carried out 5~7 days post surgery. 
Oxygen-Glucose Deprivation (OGD) Procedures  Following procedures were carried out 
5~7 days post surgery.  Medium of the plated primary neurons were replaced with Ringer’s 
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solution (116.4 mM NaCl, 5.4mM KCl, 1.8mM CaCl2, 0.8mM MgSO4, 2.6mM NaH2PO4, 
26.2 mM NaHCO3, 5.6mM glucose, and 20.1mM HEPES) for the normoxic control group;  
prepurged with N2 and glucose excluded Ringer’s solution was used for the OGD treatment 
group.  The OGD treatment group was placed in a Billups-Rothenberg modulator incubator 
chamber (Billups Rothenberg, Del Mar, CA) and purged with N2 at 37°C for 2 h.  After OGD 
treatment, original primary neuron culture medium was replaced for both treated and control 
groups and re-oxygenated for either 6, 12 or 24 h under original cell culture environment, 
incubating at 37°C in a humidified atmosphere containing 5% CO2. 
DNA Fragmentation Cell Death Detection  Primary neurons were plated in 24 well plates 
and after OGD treatment, cells were collected and Cell Detecion ELISA Plus assay kit 
(Roche Diagnostics) was performed according to the manufacturer assay instructions and 
also described previously (Kaul et al., 2003).  OGD-treated cells were washed with PBS and 
cell pellets were then resuspended with the lysis buffer from the assay kit.  The lysates were 
spun down at 200g for 10 min after 30 min incubation in lysis buffer and 20μL of the 
supernatant was incubated for 2 h with the mixture of HRP-conjugated antibody.  After 
washing away the unbound components, final reaction product was measured 
colorimetrically with 2,2’-azino-di-[3-ethylbenz-thiazoline sulfonate] as a HRP substrate 
using SpectorMax 190 Spectrometer (Molecular Devices) at 405nm and 490nm.  The 
difference of absorbance between OD405 and OD490 was used to evaluate the actual DNA 
fragmentation levels.  Values were normalized to protein concentrations obtained through 
Bradford (Bio-Rad, Hercules, CA) protein assay.   
Lactate Dehydrogenase (LDH) Assay  After desired re-oxygenation time of the OGD-
treated cells, supernatants were collected from each well including the control group and 
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centrifugation was done to obtain cell-free extracellular supernatant.  Incubation of the 
supernatant with the appropriate reagent mixture was prepared according to the instructions 
from the Cytotoxicity Detection Kit (Roche Diagnostics) at room temperature for 30 min.  
Intensity of color change was measured at 490nm proportional to LDH activity. 
Live-Dead Cell Staining Kit - Propidium iodide (PI) Staining  Cell viability was detected 
with Live-dead cell staining kit (BioVision, Mountain View, CA).  Primary neurons were 
grown in 24 well plates and after 2 h of OGD treatments, cells were re-oxygenated for 12 or 
24 h.  Medium was removed and incubation buffer containing 2.5μg/mL PI, provided by the 
manufacturer, was incubated with the cells for 20 min at 37°C. Samples are then mounted 
onto glass slides and immediately observed under excitation 488nm and emission of 615nm 
under Nikon inverted fluorescence microscope (model TE-2000U, Nikon, Tokyo, Japan).  
Images are captured with SPOT digital camera (Diagnostic Instruments, Inc., Sterling 
Heights, MI) and analyzed with MetaMorph 5.7 analysis software (Universal Imaging).  Live 
and dead cells were counted and statistically analyzed with Graphpad 3.0 software.   
Subcellular Fractionation and Western Blot Analysis   Mitochondrial and cytoplasmic 
fractions were isolated from cell lysates using differential centrifugation as described in Qin 
et al., 2004.  The crude mitochondrial suspension was further purified using a sucrose 
gradient (Sun et al., 2007).  15~30μg of proteins were loaded in each lane and resolved in 
10~15% SDS-PAGE.   After separation, proteins were transferred onto nitrocellulose 
membranes, and non-specific binding sites were blocked with blocking buffer (Bio-Rad, 
Hercules, CA).  Primary antibodies were incubated in blocking buffer with the following 
dilutions,  including anti-PKCδ (1:1500; Santa Cruz Biotechnology Inc., Santa Cruz, CA), 
anti-cytochrome c (1:500; BD Biosciences Pharminogen, San Jose, CA), Cox-IV (1:1000; 
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Invitrogen, Carlsbad, CA) and β-actin (1:5000; Sigma, St. Louis, MO) was incubated to 
confirm equal protein loading.  After overnight incubation of primary antibodies at 4°C, 
membranes were washed several times and incubated with IR Dye 800-conjugated anti-rabbit 
IgG (1:5000) or Alexa Flour 680-conjugated anti-mouse IgG (1:10000; Molecular probes, 
Invitrogen) for 1 h at room temperature.  Membranes were scanned using the Odyssey IR 
Imaging system (LICOR) and data were analyzed with Odyssey 2.0 software.   
MitoTracker Staining and Immunocytochemistry  MitoTracker Red CMXRos (Invitrogen, 
Carlsbad, CA) was used for mitochondrial targeted staining.  Staining procedures were 
carried out according to the manufacturer’s protocol.  In brief, cells were incubated with 
0.5μM of MitoTracker Red CMXRos at 37°C for 20 min, and then fixed with 4% 
paraformaldehyde.  Dual immunostaining with primary antibodies including goat anti-
caspase-3 (1:250; Santa Cruz Biotechnology) or goat anti-cytochrome c (1:500; Santa-Cruz) 
was diluted in 5% donkey blocking serum and incubated with samples overnight at 4°C.  
Alexa Flour 488-conjugated donkey anti-goat IgG was used as secondary antibody diluted in 
PBS and incubated with the cells for 1hour.  Finally, nucleus staining with Hoechst 33342 
was incubated for 1min at a final concentration of 10μg/ml before mounting onto slides.  
Images were taken with the fluorescent microscope using the 60x objective.  
Western Blot Analysis  Treated cells were collected and lysed with RIPA buffer in ice and 
sonicated for 15 seconds on ice for each sample.  Samples were centrifuged at 100,000 g for 
40 min at 4°C.  Supernatants were collected and protein assay was done for equal loading of 
proteins.  Western blot analysis was done as previously described (Sun et al., 2005).  
Samples were sonicated on ice for 15 seconds and lysates were centrifuged 100,000g for 50 
min.  Supernatants were collected for protein assay and equal amounts of proteins were 
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separated with 10% SDS-PAGE and transferred onto nitrocellulose membrane.  Standard 
Western blot procedure was done for immunoblot with overnight incubation with anti- PKCδ 
(1:1500; Santa Cruz) at 4°C and β-actin (1:5000; Sigma, St. Louis, MO) to confirm equal 
protein loading.  Membranes were washed several times and incubated with IR Dye 800-
conjugated anti-rabbit IgG (1:5000) or Alexa Flour 680-conjugated anti-mouse IgG (1:10000; 
Molecular probes, Invitrogen) for 1 h at room temperature.  Membranes were scanned using 
the Odyssey IR Imaging system (LICOR) and data were analyzed with Odyssey 2.0 software.   
Hoechst Staining  Hoechst 33342 is a specific staining for the nucleus, incubating for 1min 
at a final concentration of 10μg/ml before mounting onto slides.  Apoptotic cells are 
represented by the small and shrunken nuclei in contrast to the healthy large nuclei.  
Apoptotic and healthy cells are counted and statistically analyzed.  Five microscopic views 
under 10x magnification are chosen and counted from each sample, numbers are calculated 
and graphed. 
TUNEL Staining and Immunocytochemistry  Primary striatal neurons were plated on 
poly-D-lysine pre-coated cover glass in 24 well plates and 2 h of OGD was performed.  After 
24 h of re-oxygenation, fixation was done with 4% paraformaldehyde.  Samples were 
incubated with primary antibodies, rabbit anti-PKCδ (1:1000; Santa Cruz Biotechnology) or 
rabbit anti-GAD67 (1:250; Santa Cruz Biotechnology), in 5% donkey blocking serum 
overnight at 4°C.  Secondary antibody, Alexa Flour 488-conjugated donkey anti-rabbit IgG 
(1:2000; Molecular Probes, Eugene, OR) was used for incubation in PBS for 1 hour.  
Terminal deoxynucleotidyl transferase-mediated biotin-dUTP nick-end labeling (TUNEL) 
staining was done according to the instructions provided by the manufacturer (Roche 
Diagnostics).  In brief, after completion of secondary antibody, cells grown on cover glass 
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were incubated with the staining mixture from the kit at 37°C for 60 min in the dark.  Finally, 
nuclei staining was done with Hoechst 33342, incubating for 1min at a final concentration of 
10μg/ml before mounting onto slides.  
Caspase Enzymatic Activity Assay  Caspase-9 and caspase-3 activity was measured using a 
specific fluorescent substrate, Ac-LEDH-AFC (caspase-9) and Ac-DEVD-AFC (caspase-3), 
as described previously (Kaul et al., 2003).  Briefly, cells were lysed with lysis buffer (50mM 
Tris HCl, 1mM EDTA, and 10mM EGTA) containing 10mM digitonin for 30 min at 37°C.  
Lysates were centrifuged at 10,000g for 5 min and cell-free supernatants were collected.  
Supernatants were incubated with fluorogenic substrate Ac-LEDH-AFC or Ac-DEVD-AFC 
for 2 h at 37°C and fluorescence was measured with Gemini XS fluorescence plate reader 
(Molecular Devices) at excitation 400nm and emission at 505nm.  The measured values were 
normalized to protein concentrations from the samples with Bradford protein assay (Bio-rad, 
Hercules, CA).   
Mitocasp Dual Staining  Dual staining of mitochondria and caspase3/7 was done with a 
commercial kit, MitoCasp (Cell Technology Inc., Mountain View, CA).  Primary neurons 
were objected to 2 h OGD and re-oxygenated for 24 h.  Following to the manufacturer’s 
instructions, Mitochondria Membrane Potential Dye and Caspase detection reagent mixture 
was added to the cells and incubated at 37°C for 60 min. After incubation, samples were 
washed with PBS and images were captured immediately under Nikon inverted fluorescence 
microscope (model TE-2000U, Nikon, Tokyo, Japan); captured with SPOT digital camera 
(Diagnostic Instruments, Inc., Sterling Heights, MI).  Images were analyzed with MetaMorph 
5.7 analysis software (Universal Imaging).  Caspase detection was done under excitation 
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wavelength 488nm, emission wavelength 515-530nm.  Mitochondria membrane potential 
detection was done under excitation wavelength 549nm and emission 574nm.   
Immunocytochemistry  Primary striatal neurons were plated on poly-D-lysine pre-coated 
cover glass in 24 well plates after 2 h of OGD procedure.  Upon re-oxygenation for 24 h, 
cells were fixed with 4% paraformaldehyde.  Following fixation, samples were blocked with 
blocking buffer containing 5% goat/donkey serum, 0.4% BSA, 0.2% Triton X-100 for 1 h at 
room temperature.  Dual immunostaining is done with primary antibodies including rabbit 
anti-GAD67 (1:250; Santa Cruz Biotechnology) and mouse anti-PKCδ (1:1000; Santa Cruz 
Biotechnology).  Primary antibodies were incubated overnight at 4°C in 5% goat serum 
blocking buffer.  Secondary antibodies, including Alexa Flour 488-conjugated goat anti-
rabbit IgG or Alexa Flour 555-conjugated goat anti-mouse IgG (1:2000; Molecular Probes, 
Eugene, OR), were diluted in PBS for 1 hour incubation at room temperature.  PBS was used 
for washing in between steps. Nuclei were stained with Hoechst 33342 at a final 
concentration of 10μg/ml for 1 min.  Finally, cells were washed with PBS and mounted with 
anti-fade mounting medium.  Slides were viewed under Nikon inverted fluorescence 
microscope (model TE-2000U; Nikon, Tokyo, Japan); captured with SPOT digital camera 
(Diagnostic Instruments, Inc., Sterling Heights, MI).  Images were analyzed with MetaMorph 
5.7 analysis software (Universal Imaging).  
Data Analysis and Statistics All data analysis was first performed with InStat 3.0 
(GraphPad software, San Diego) and then graphed with Prism 4.0 software.  One-way 
ANOVA was used for multiple comparisons and single comparisons were done using the 
Student’s t-test.  Student Newman Keuls was used for post analysis.  p<0.05 was considered 
as significant difference.  
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RESULTS 
OGD induces neuronal death in primary striatal neurons 
To investigate the vulnerability of primary striatal neurons to neuronal injury 
following ischemia, we utilized a commonly used in vitro model of OGD.  Previous work has 
demonstrated that exposure of murine cortical culture to 2 h of OGD leads to delayed 
neuronal death and is mediated via caspase-3 signaling pathway (Namura et al., 1998; Gill et 
al., 2002); however, studies in striatal neurons are still lacking.  Hence, to characterize the 
time course of OGD-induced neuronal injury in striatal neurons, we exposed wild type 
striatal cultures to 2 h of OGD or normaxic conditions (NML) and cell death was assessed at 
12 and 24 h following reperfusion.  OGD treatments resulted in 50, 40 and 100% increase in 
neuronal loss at 6, 12, 24 h respectively, as assessed by a cell death oligonucleosome 
enzyme-linked immunoabsorbant assay (ELISA) (Fig. 1A).  Furthermore, the neuronal death 
at 12 and 24 h of reoxygenation after exposure to OGD for 2 h was investigated using PI 
uptake and LDH release studies, routinely used methods for studying cell death (please see 
methods and materials section for details).  We found only a few PI-positive cells in control 
cells exposed to normaxic conditions while in cells exposed to OGD and reoxygenation for 
12 and 24 h respectively, an average increase in fluorescence of 30 and 35% respectively 
(p<0.001) were evidenced (Fig. 1B).  The difference between 12 and 24 h is not very 
significant (p<0.05).  In a comparable study using LDH release as an endpoint, release of 
LDH into the medium following 2 h of OGD increased with increasing period of 
reoxygenation.  Reoxygenation for 6, 12, 24 h resulted in an increase of 55, 35 and 50% 
respectively as compared to control cells exposed to normaxic conditions (p<0.001).  Taken 
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together, these results demonstrate that cultured mouse striatal neurons are vulnerable to 
OGD-induced neuronal injury. 
 
OGD induces dissipation of MMP and mitochondrial release of cytochrome c in striatal 
neurons 
 In the next set of experiments, we studied the status of mitochondrial function 
preceding and during OGD-induced striatal neuronal degeneration.  To achieve this, 
measurements of MMP and mitochondrially released factors, such as cytochrome c, were 
performed.  MitoTracker red, a mitochondrial stain that is actively taken up by live 
mitochondria, was used to study the impact of OGD on striatal neuronal MMP.  Following 
exposure of striatal neurons to 2 h of OGD and 12 h of reperfusion of neurons in normaxic 
conditions were stained with MitoTracker red and the MMP changes were visualized by 
fluorescence microscopy.  Results showed decreased intensity of staining in OGD-treated 
cells (Fig 2A), suggesting membrane depolarization.  However, in control cells the intensity 
of staining was more pronounced suggestive of normal respiring mitochondria.  
Mitochondrial membrane depolarization leads to release of apoptotic factors including AIF 
and cytochrome c.  Subsequently, we performed dual labeling studies to determine 
mitochondrial translocation of cytochrome c.  At 12 h of reoxygenation after OGD, striatal 
neurons displayed a decrease in MitoTracker uptake accompanied by a diffuse distribution of 
cytochrome c, whereas a punctate distribution of cytochrome c immunostaining were 
evidenced in cells exposed to normaxic conditions, suggestive of mitochondrial release of 
cytochrome c (Fig 2B).  To further confirm the mitochondrial release of cytochrome c in 
striatal neurons following OGD exposure, immunoblot analysis was performed.  As shown in 
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Fig 2C, cytochrome c levels in the cytosol is increased in OGD-treated cells as compared 
with control cells exposed to normoxic conditions.  Taken together, our studies suggest that 
OGD-induced striatal cell death is mediated by loss of MMP and associated release of 
cytochrome c. 
 
OGD induces caspase-9 and -3 activation in striatal neurons 
 Mitochondrial release of cytochrome c is a well-established upstream activator of 
caspase-9 and -3 (Kojima, 1998; Tafani et al., 2000).  Caspase-3 plays a central role in the 
execution of apoptotic cell death in both neuronal and non-neuronal cells.  In the present 
study, we evaluated the effect of OGD on caspase activation in striatal neurons.  As shown in 
Fig. 3A, caspase-9 activity increased 30% at 12 h post OGD (p<0.05).  However, csapse-9 
activity was absent in striatal neurons derived from PKCδ-KO mice.  Next, we measured the 
activity of caspase-3, as effector caspase.  Similar to caspase-9 activation, exposure of striatal 
neurons to 2 h OGD followed by reperfusion for 12 and 24 h respectively resulted in a 1.5 
and 3 -fold increase in caspase-3 activity (Fig 3A).  This elevation was also absent in striatal 
neurons derived from PKCδ-KO mice.  To confirm the mitochondrial involvement of 
caspase-3 activation, we performed immunofluorescence studies to determine whether 
depolarized mitochondria colocalized with caspase-3.  As shown in Fig. 3B and C, we found 
marginal activation of caspase-3 in control neurons; however, in OGD-treated neurons, a 
pronounced increase in caspase-3 staining.  Together, the data indicate that caspase-9 
activation precedes caspase-3 activation and may be partly mediated via mitochondrial 
dysfunction during OGD-mediated cell death of striatal neurons. 
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OGD triggers proteolytic processing of PKCδ in striatal neurons 
PKCδ is a critical target of caspase-3 and a downstream protein implicated in 
oxidative stress-induced neuronal loss (Kaul et al., 2005; Kanthasamy et al., 2003).  Recently, 
we and others have demonstrated that PKCδ may be an endogenous substrate for caspase-3 
(Raval et al., 2005; Latchoumycandane et al., 2005).  Activated caspase-3 cleaves PKCδ to a 
38-kDa regulatory and 41-kDa catalytic fragment to enable persistent increase in kinase 
activity.  As shown in Fig. 4A in control cultures (NML), the levels of cleaved PKCδ (34 and 
44 kDa) fragments were low.  OGD induced a marked increase in cleaved PKCδ in striatal 
neurons, evidenced at 12 and 24 h as compared to control culture.  The data suggests that 
PKCδ might be critically involved in OGD-induced cell death of primary striatal neurons. 
 
PKCδ deficiency confers resistance to OGD-induced striatal neuronal injury 
To test the hypothesis that PKCδ not only mediates but also accompanies neuronal 
cell death during cerebral ischemia, we studies the effects of OGD on wildtype (WT) and 
PKCδ-KO cultured striatal neurons.  As shown in Fig. 5A, 24 h after OGD, WT cells display 
condensed and brightly stained nuclei, consistent with apoptotic mode of cell death, whereas 
in cells cultured from PKCδ-KO mice, this type of staining pattern was rather sparse.  Cell 
counting showed 180% increase in the number of condensed nuclei as compared with WT 
cells that were exposed to nomoxic conditions.  However, the corresponding increase in 
condensed nuclei in PKCδ-KO neurons was only 50%, thus constituting a 130% decrease in 
cell death following OGD in PKCδ-KO cells.  In a comparative study using LDH analysis, 
cultured neurons from PKCδ-KO mice were resistant to OGD-induced LDH release (Fig. 5B).  
In fact, a complete reversal of OGD-induced LDH release was observed in striatal neurons 
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cultured from PKCδ-KO mice as compared to WT animals.  To confirm that PKCδ activation 
occurs in dying neurons, we studied the extent of localization of PKCδ to terminal 
deoxynucleotidyl transferase-mediated biotin-dUTP nick-end labeling (TUNEL)-positive 
neurons by immunofluorescence studies.  PKCδ deficient neurons exhibited decreased 
TUNEL-positive staining and colocalization with PKCδ immunopositive cells in contrast to 
WT neurons (Fig. 5C) exposed to OGD.  The data is consistent with the model in which 
PKCδ is a central mediator of OGD-induced cell death. 
 
PKCδ expression in GAD67-posotive neurons and increased staining for TUNEL 
following OGD 
 To investigate whether PKCδ may act as a deleterious factor in the demise of 
GABAergic neurons following OGD, we first asked whether PKCδ is expressed by 
GABAergic neurons in culture.  Fig. 6A depicts dual immunolabeling for PKCδ and GAD67, 
GABAergic neuronal marker. As demonstrated in the merged images, GABAergic neurons 
in culture express PKCδ.  In normoxic control, a moderate level of PKCδ staining was 
evidenced, however, in OGD-treated neurons, an intense PKCδ staining was evidenced 
suggesting an upregulation of PKCδ in GAD67-positive neurons.  In an effort to determine 
the neurodegenerative capacity of GAD67- positive neurons, we performed TUNEL staining 
to assess the extent of apoptotic nuclei.  As shown in Fig. 6B, control striatal neurons showed 
weak TUNEL staining in GAD67-positive neurons, whereas in neurons exposed to OGD for 
2 h and 24 h reperfusion, several GAD67-positive cells stained positively for TUNEL.  The 
increase in TUNLE-positive staining in GAD67 immunoreactive neurons suggests that 
GABAergic neurons are vulnerable to OGD-induced striatal injury.  Collectively, these data 
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suggest that PKCδ might be a critical mediator in the demise of GABAergic neurons 
following exposure of striatal culture to OGD. 
 
DISCUSSION 
Majority of the studies in ischemic research have focused on either cortical or 
hippocampal regions; however, the cellular mechanisms underlying increased vulnerability 
of the striatum, a dopamine enriched brain region to ischemia-induced brain damage remains 
poorly understood.  In our study, cerebral ischemia is modeled by exposing primary striatal 
neurons to OGD environment.  This model of oxidative stress is believed to mimic ischemic 
situations occurring in the brain following cerebral ischemia (Ravel et al., 2005).  Multiple 
complementary methods including DNA fragmentation, LDH activity and live-and-dead cell 
kit have been used to demonstrate striatal ischemic cell death (Fig. 1).  The critical role of 
mitochondria in regulating cerebral ischemia has been demonstrated through various 
chemical inhibitory studies, utilizing lidoflazine and nortriptyline, specifically targeted for 
the protection of mitochondria from ischemic damage caused by stroke (Rosenthal et al., 
1987; Zhang et al., 2008).  A major proapoptotic event that follows mitochondrial stress is 
cytochrome c release, which is a critical step in the evaluation of cell death after cerebral 
ischemic insult (Fujimura et al., 1998; Saguwara et al., 1999).  A downstream signaling event 
is the activation of caspase-3, an effector protease that plays the execution role in apoptotic 
cell death, including cerebral ischemia-induced injury (Manabat et al., 2003).  Furthermore, 
other studies have shown that genetic knockdown of caspase-3 results in neuroprotection in 
ischemic insult (Le et al., 2002).  Our findings in the present study are indeed consistent with 
existing literature, aimed at studying the importance of mitochondrial events in cerebral 
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ischemia. Similarly, we have observed similar form of oxidative stress-induced cell death 
events in our studies, including loss of MMP followed by cytochrome c release (Fig. 2) and 
caspase-3 activation in primary striatal neurons subjected to OGD treatment (Fig. 3).  
In the present study, we have shown PKCδ-positive neurons in primary striatal 
culture and their colocalization with TUNEL staining in 24 h post OGD-treated neurons (Fig. 
6).  We have also provided evidence that PKCδ is activated via proteolytic cleavage (Fig. 4), 
suggesting the mediatory role of PKCδ in OGD-induced neuronal death.  Our findings are 
consistent with other studies demonstrating the central role of PKCδ in hippocampal 
neuronal demise (Raval et al., 2005).  Likewise, studies from our lab demonstrated that H2O2 
induced oxidative stress resulted in cell death in N27 dopaminergic cells and was proven to 
occur via mitochondria mediated oxidative stress (Kaul et al., 2005). In recent years, our lab 
has repeatedly demonstrated the importance of mitochondrial cell death pathways involving 
PKCδ proteolytic cleavage in mediating dopaminergic neuronal degeneration in N27 
dopaminergic cells exposed to diverse Parkinsonian toxins (Kaul et al., 2003; Yang et al., 
2004).  Taken together, our results suggest that proteolytic activation of PKCδ may be a 
master regulator in ischemia-induced brain damage evidenced. 
PKCδ is a member of the novel PKC family that can be activated by various forms of 
cellular stimuli through several mechanisms.  Some of these modes of activation include 
membrane translocation (Joseloff et al., 2002; Sun et al., 2000), tyrosine phosphorylation 
(Kaul et al., 2005; Denning et al., 1996), proteolytic cleavage by activated enzymes 
(Kanthasamy et al., 2003; Reland et al, 1999; Denning et al., 2002) and more recently, a 
nuclear localization signal has been identified in the C-terminal region of PKCδ (DeVries et 
al., 2002) that suggests a possibility of nuclear targeting by the catalytically activated PKCδ.  
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It appears that different modes of PKCδ activation are highly dependent on the type of cell 
line, the stimulus and the expression characteristic of PKCδ.  In our ischemic model, we 
demonstrated activation of caspase-3 induced proteolytic cleavage of PKCδ in primary 
striatal neurons.  As of now the role of PKCδ in cerebral ischemia research have focused on 
cortical ischemia or hippocampal ischemia (Bright et al., 2004; Koponen et al., 2000), our 
study provides novel evidence for the participation of PKCδ in striatal ischemia and data on 
PKCδ activation via caspase-3 dependent mechanism (Fig. 4).  The apoptotic role of PKCδ is 
also confirmed in PKCδ knockdown studies, where cell death is attenuated in striatal neurons 
derived from PKCδ-KO mice (Fig. 5). 
Further, in depth studies revealed subtype specific vulnerability of GABAergic 
neurons to ischemic insults, colocalizing with TUNEL (Fig. 6B).  The colocalization of 
PKCδ within GABAergic neurons shown in Fig. 6A suggests that the increased vulnerability 
of GABAergic neurons may be partly explained by PKCδ mediated regulation of ischemic 
cell death pathway.  Taken together, these results suggest that caspase-3 dependent 
proteolytic activation of PKCδ is a key regulatory event that serves as a trigger in the demise 
of GABAergic neuronal phenotypes during ischemic insult to the striatum.  Further studies 
are warranted to study the striatal neuronal subtype specific vulnerability to ischemia-
induced brain damage.  This may lead to the development of novel therapeutic strategies in 
the treatment of stroke. 
 In conclusion, our study presents data on the regulatory role of caspase-dependent 
PKCδ activation in striatal ischemia induced by OGD methods.  Dysfunction of the 
mitochondria is also shown via classical characteristic events such as depolarization of 
mitochondrial membrane potential and release of proapoptotic factors namely cytochrome c.  
99 
 
  
Close examination of striatal neuronal vulnerability to OGD revealed that GABAergic 
neurons, which are PKCδ positive, are particularly vulnerable to reperfusion-associated 
neuronal injury.  The resistance of PKCδ-deficient neurons to OGD-induced apoptotic cell 
death and associated attenuation of mitochondria-dependent cell death signaling events 
highlight the critical role of PKCδ  in mitochondria-mediated cell death signaling events in 
primary striatal cultures.   
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FIGURE 1. 
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Figure 1.  OGD-induced striatal cell death.  A, DNA fragmentation analysis was done at 6, 
12 and 24 h post OGD treatment in primary striatal neurons and compared to cells in 
normoxic conditions (NML).  Data represents results from six individual measurements and 
are expressed as mean+/-S.E.M.  Asterisks (**p<0.01, ***p<0.001) indicate significant 
difference compared to control group (NML).  B, Live-dead cell staining (PI) revealed 
immunostaining  of healthy and apoptotic shown in green and red fluorescence respectively.  
Primary striatal neurons were treated with OGD and PI staining was done 12 and 24 h post 
OGD.  Cells were counted from 5 microscopic views under 10x magnification for each 
sample and numbers are calculated and graphed. Asterisks (***p<0.001) indicate significant 
difference compared to control group (NML), and pound signs (#p<0.05) indicate significant 
differences in 12 and 24 h. C, LDH assay revealed cell death levels in 6, 12 and 24 h post 
OGD-treated primary neurons.  Data represents results from six individual measurements and 
are expressed as mean+/-S.E.M.  Asterisks (***p<0.001) indicate significant difference 
compared to control group (NML). 
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FIGURE 2. 
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Figure 2.  OGD-induced mitochondrial impairment involves dissipation of membrane 
potential and mitochondrial release of cytochrome c.    A, MMP was shown with 
MitoTracker red staining in 12 h post OGD-treated primary neurons and compared with cells 
under normaxic conditions (NML).  Neurons were fixed, stained and viewed under a Nikon 
TE2000 fluorescence microscope at 10x magnification.  B, Dual immunostaining with 
MitoTracker and cytochrome c was done in 12 h post OGD-treated primary neurons.  
Colocalization of mitochondria (red) and cytochrome c (green) was observed and images 
were taken under 60x magnification under a Nikon TE2000 fluorescence microscope. C, 
Western blot analysis was used to detect cytochrome c (15kDa) in both cytosolic and 
mitochondrial compartments in 12 h post OGD-treated primary neurons.  Cox-IV (17kDa) 
was detected as a marker for mitochondria, determining the cellular fractionation procedure.  
β-actin was detected for equal protein loading. 
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FIGURE 3. 
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Figure 3.  Mitochondria regulates ischemic cell death in PKCδ-WT cells via caspase-3 
mediated PKCδ pathway.  A, Caspase-9 and -3 activity was detected in both OGD-treated 
PKCδ-WT and -KO primary neurons, detailed procedures are described in the methods 
section. Caspase-9 activity was detected in 12 h post OGD-treated neurons and caspase-3 
activity was detected in 12 and 24 h post OGD-treated neurons.  Data represents results from 
six individual measurements and are expressed as mean+/-S.E.M.  Asterisks (*p<0.05, 
**p<0.01) indicate significant difference compared with control group (NML).  B, MitoCasp, 
a dual staining that detects mitochondria (red) and caspase-3/7 (green), was used for 
immunostaining in 24 h post OGD-treated PKCδ-WT primary striatal neurons. C, Dual 
immunostaining methods detected for Mitotracker (red) and caspase-3 (green) in 12 h post 
OGD-treated PKCδ-WT primary neurons.  All images were viewed and taken under a Nikon 
TE2000 fluorescence microscope under 60x magnification.    
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FIGURE 4. 
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Figure  4.  OGD triggers proteolytic cleavage of PKCδ in striatal neurons.  Western blot 
studies detected for cleaved PKCδ (41 kDa) in samples derived from 12 and 24 h post OGD-
treated primary neurons and compared to control group (NML).  β-actin (43 kDa) was 
reprobed for equal protein loading. Please see methods section for detailed procedure.   
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FIGURE 5. 
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Figure 5.  Ischemic cell death is attenuated in primary neurons from PKCδ-knockout 
(KO) mice compared to PKCδ-wildtype (WT) mice.  A, Both PKCδ-WT and -KO primary 
neurons were stained with Hoechst 3324 for nuclei morphology studies at 24 h post OGD 
treatment. Apoptotic cells and healthy cells are distinguished and counted with a Nikon 
TE2000 under 10x magnification.  Asterisks (***p<0.001) indicate significant difference 
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compared with control group (NML) and pound sign (##p<0.01) indicate significant 
differences between OGD-treated PKCδ-WT and -KO neurons.  B, LDH activity was 
assessed in 24 h post OGD-treated PKCδ -WT and -KO neurons. Medium was collected for 
detection, details are described in methods section. Data represents results from six 
individual measurements and are expressed as mean+/-S.E.M.  Asterisks (**p<0.01) indicate 
difference compared with control group (NML).  C, Dual immunostaining method was used 
to detect for PKCδ and TUNEL 24 h post OGD-treated PKCδ-WT and –KO neurons and 
compared to cells under normoxic conditions (NML).  Samples were viewed and pictures 
were taken with a Nikon TE2000 fluorescence microscope under 60x magnification. 
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FIGURE 6. 
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Figure 6.   Striatal GABAergic neurons are immune-positive for PKCδ and colocalize 
with TUNEL.  A, Dual immunostaining methods is used to detected PKCδ-positive neurons 
(red) and GABAergic (GAD67)-positive neurons (green) in 12 h post OGD-treated cells.  B, 
Dual immunostaining also revealed GABAergic (GAD67)-positive neurons colocalize with 
δ 
KCδ 
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TUNEL in 12 h post OGD-treated cells compared to control cells (NML).  Samples were 
viewed and pictures were taken with a Nikon TE2000 fluorescence microscope under 60x 
magnification. 
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Chapter VI:  General Conclusions 
 
GENERAL CONCLUSIONS 
The major goal of my project is to understand the cellular mechanisms underlying 
dopaminergic and striatal neurodegeneration.  Although oxidative stress and apoptosis are 
considered key mediators during delayed ischemic cell death and MA-induced neurotoxicity 
process, the downstream executioner events that lead to DNA fragmentation subsequent to 
caspase-3 activation are currently not well established.  Furthermore, the contribution of 
autophagy in the mechanism of neurodegeneration is poorly understood.  Based on our 
experimental findings, together with existing literature, we propose that local 
microenvironment, type of stressor, magnitude of induction of the cell death pathway might 
be key determinants in the implementation of specific type of cell death pathways.  We 
propose the following model for the neuronal cell death mechanisms induced by MA and 
OGD in dopaminergic and striatal neurons, respectively:  
 
Pathway 1: 
PKCδ was activated via proteolytic cleavage in both models.  Furthermore, the regulatory 
role of PKCδ in cell death was demonstrated by cytoprotection in MA-treated CRM cells.  
Moreover, inhibition of PKCδ activation resulted in significantly reduced caspase-3 activity 
and associated apoptotic cell death; hence underscoring the central role of PKCδ in mediating 
apoptotic cell death in response to MA. 
The important role of mitochondria in mediating cell death pathway was discovered by 
experiments monitoring MMP during MA treatments and the dissipation of MMP that 
resulted in mitochondrial release of cytochrome c release and activation of the downstream 
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cell death signaling events.  Our findings emphasize the importance of intrinsic pathway in 
mediating the demise of dopaminergic neurons following exposure to MA.  A well-
maintained protein clearance system is essential for cellular wellbeing.  In the context, the 
presence of elevated levels of ubiquitinated proteins has been considered to be an important 
hallmark of neurodegenerative disease.  In fact, MA induces massive accumulation of 
ubiquitin-positive intracellular bodies within dopaminergic neurons.  Defective UPS function 
could result from oxidative stress when oxidatively damaged proteins overwhelm the 
degradation capacity of proteasome.  This is consistent with our findings showing 
downregulation of proteasomal activity and accumulation of ubiquitinated proteins 
associated with MA-induced cell death.  Furthermore, emerging evidence indicate that 
impaired proteasomal system can cause the induction of autophagy, which is considered to be 
a compensatory mechanism believed to aid in the clearance of aggregated proteins.  However, 
MA-induced autoaphgy is less investigated and less is known regarding the association 
between UPS and autophagy in neurotoxicity models.  Our findings point to a putative cross 
talk between UPS and autophagy in MA-induced cell death, by showing colocalization of 
ubiquitin and LC3 in MA-treated neurons.  The role of autophagy in cell death is a strongly 
debated issue and remains controversial.  Our results suggest autophagy may play a 
neuroprotective role in MA-induced cell death to minimize the magnitude of neurotoxicity 
(Scheme 1- Pathway 1).  However, we propose that the neuroprotective intentions of 
autophagy may eventually be overwhelmed by increasing proapoptotice signals or maybe 
due to dysfunction of the ALS, shifting the autophagy-apoptosis balance toward apoptosis. 
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Pathway 2: 
OGD leads to mitochondrial dysfunction, hence causing the induction of mitochondria –
mediated deleterious intrinsic cell signaling events resulting in the release of proapoptotic 
factors including cytochrome c subsequently leading to the induction of downstream caspase-
3 dependent signaling events that facilitate the loss of GAD67-positive neuron via proteolytic 
activation of PKCδ. 
To summarize, in both MA and OGD experimental models of neurodegeneration, 
impairments in mitochondrial function facilitate proteolytic cleavage of PKCδ, thereby 
resulting in its sustained activation for protracted periods of time ensuring the successful 
dismantling of neurons via apoptotic cell death, despite a futile attempt made by autophagy 
to protect the dying neurons as in the case of MA-induced dopaminergic neuronal injury.  
Hence, the therapeutic use of antioxidants may protect neurons from further insults 
associated with age related pathogenic changes and acute insult that ultimately result in 
neuronal demise.  In addition, agents that cause a moderate enhancement in autophagy may 
be beneficial in the treatment of neurodegenerative diseases including PD and cerebral 
ischemia. 
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Scheme 1 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.  Diverse pathways participate in cell death mechanisms.  Mitochondria appear 
to play a central role in the induction of several of the cell signaling pathways as depicted.  In 
this context, PKCδ acts as a master regulator in the regulation of diverse cell signaling 
mechanisms.  Normal cellular function is governed by a balance between homeostatic and 
deleterious factors.  Once the neuron is overwhelmed by a particular level of stress response, 
the cell is committed to apoptotic cell death irrespective of the induction of the cytoprotective 
response, namely autophagic response. 
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